| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abstract converted to O-09.
|
|
|
|
122-123 |
S |
p. S38
|
article
|
| 2 |
Abstract converted to O-26.
|
|
|
|
122-123 |
S |
p. S56
|
article
|
| 3 |
Abstract converted to P-85
|
|
|
|
122-123 |
S |
p. S11
|
article
|
| 4 |
ABSTRACT REVIEWERS
|
|
|
|
122-123 |
S |
p. iii
|
article
|
| 5 |
ABSTRACT REVIEWERS
|
|
|
|
122-123 |
S |
p. ii
|
article
|
| 6 |
ABSTRACT REVIEWERS
|
|
|
|
122-123 |
S |
p.
|
article
|
| 7 |
Abstract withdrawn.
|
|
|
|
122-123 |
S |
p. S53
|
article
|
| 8 |
Abstract withdrawn.
|
|
|
|
122-123 |
S |
p. S38
|
article
|
| 9 |
Abstract withdrawn.
|
|
|
|
122-123 |
S |
p. S47
|
article
|
| 10 |
Abstract withdrawn.
|
|
|
|
122-123 |
S |
p. S61
|
article
|
| 11 |
Abstract withdrawn.
|
|
|
|
122-123 |
S |
p. S61
|
article
|
| 12 |
Accelerator-produced actinium-225 under the US DOE Tri-Lab collaboration: 2022 update
|
Burgoyne, Andrew
|
|
|
122-123 |
S |
p. S42-S43
|
article
|
| 13 |
Accelerator production of 71As from metal germanium targets
|
Lo, Yi-Hsuan
|
|
|
122-123 |
S |
p.
|
article
|
| 14 |
Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction
|
Kogler, Jürgen
|
|
|
122-123 |
S |
p. S16
|
article
|
| 15 |
227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update
|
Burgoyne, Andrew
|
|
|
122-123 |
S |
p.
|
article
|
| 16 |
225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation
|
Rodak, Magdalena
|
|
|
122-123 |
S |
p. S33
|
article
|
| 17 |
A clickable C-glycosyl scaffold for RGD peptide dimer labelling and application in bimodal [18F]PET/NIRF imaging
|
Jouad, Kamal
|
|
|
122-123 |
S |
p. S42
|
article
|
| 18 |
A Comparison of Cation Exchange and Extraction Resin Column-based Chromatography Methods for Isolating MURR Produced 161Tb
|
Bokolo, Patrick
|
|
|
122-123 |
S |
p.
|
article
|
| 19 |
A comparison of rhenium isolation and tungsten recovery methods from bulk tungsten targets
|
Charles, Anster
|
|
|
122-123 |
S |
p. S104
|
article
|
| 20 |
A convenient tritiation strategy for tetrazines
|
Bidesi, Natasha
|
|
|
122-123 |
S |
p. S90
|
article
|
| 21 |
Actinium-225 labeling of DOTATATE and DOTA-JR11 for the treatment of SSTR2-positive tumors
|
Handula, Maryana
|
|
|
122-123 |
S |
p. S191
|
article
|
| 22 |
Advances in the automation technologies within LARAMED project
|
Martini, Petra
|
|
|
122-123 |
S |
p. S21
|
article
|
| 23 |
A facile 18F radiochemistry of making (-)-[18F]TZ8024 for imaging VAChT and initial metabolite analysis in rat plasma and brain
|
Zhao, Haiyang
|
|
|
122-123 |
S |
p. S39
|
article
|
| 24 |
A facile radiosynthesis of [18F]FBA-Pep42, a cyclic peptide targeting glucose-regulated protein 78 (GRP78)
|
Yang, Hao
|
|
|
122-123 |
S |
p. S72
|
article
|
| 25 |
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben
|
Akula, Hari
|
|
|
122-123 |
S |
p. S85
|
article
|
| 26 |
A fluorescent probe as a lead compound for a potential α-syn PET tracer: design and development of a library of RB1 derivatives
|
Di Nanni, Adriana
|
|
|
122-123 |
S |
p. S94
|
article
|
| 27 |
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB
|
Di Nanni, Adriana
|
|
|
122-123 |
S |
p.
|
article
|
| 28 |
A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors
|
Hu, Kuan
|
|
|
122-123 |
S |
p.
|
article
|
| 29 |
A kit-based approach to aluminium-[18F]fluoride-labelled microbubbles and their in vivo biodistribution following ultrasound-targeted microbubble destruction
|
Teh, Jin Hui
|
|
|
122-123 |
S |
p.
|
article
|
| 30 |
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists
|
Koustoulidou, Sofia
|
|
|
122-123 |
S |
p. S191-S192
|
article
|
| 31 |
Al18F-Radiolabeling of PSMA-11 in a media of protic ionic liquids
|
Antuganov, Dmitrii
|
|
|
122-123 |
S |
p. S76-S77
|
article
|
| 32 |
ALISI – automated light-induced synthesis of 89Zr-labelled antibodies for immuno-PET
|
Klingler, Simon
|
|
|
122-123 |
S |
p. S5-S6
|
article
|
| 33 |
Alpha particle therapy for the treatment of metastatic tumors of prostate cancer
|
Bidkar, Anil
|
|
|
122-123 |
S |
p.
|
article
|
| 34 |
Alternate radiohalogens for trametinib PET imaging
|
Pratt, Edwin
|
|
|
122-123 |
S |
p. S52
|
article
|
| 35 |
Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F
|
Xiong, Hui
|
|
|
122-123 |
S |
p. S88
|
article
|
| 36 |
A 177Lu-labeled anti-HER2 dual variable domain antibody
|
MacPherson, Douglas
|
|
|
122-123 |
S |
p. S9
|
article
|
| 37 |
A multi-modality platform employing supramolecular chemistry to radiolabel antibodies
|
d’Orchymont, Faustine
|
|
|
122-123 |
S |
p. S27-S28
|
article
|
| 38 |
A multimodal SPECT: photoacoustic imaging agent for bacterial infection
|
Swann, Rowan
|
|
|
122-123 |
S |
p. S62-S63
|
article
|
| 39 |
Analysis beyond the image, new prospects in α autoradiography
|
Donnard, Jerome
|
|
|
122-123 |
S |
p.
|
article
|
| 40 |
Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model
|
Dijie, Liu
|
|
|
122-123 |
S |
p.
|
article
|
| 41 |
An approach towards reverse generator system for 99mTc separation from LSA 99Mo
|
Cieszykowska, Izabela
|
|
|
122-123 |
S |
p. S97
|
article
|
| 42 |
An effective process for radiolabelling of bioactive amines from 2,2-difluoro-2-[18F]Fluoro-ethyl 4-methylbenzenesulfonate, a versatile tool for 18F-radiotracer development
|
Maqbool, Mudasir
|
|
|
122-123 |
S |
p. S82
|
article
|
| 43 |
An Evaluation of the Production of High Specific Activity 155Tb via Alpha-Irradiation of Thick Natural Eu2O3 and Enriched [153Eu] Eu2O3 Targets
|
Charles, Anster
|
|
|
122-123 |
S |
p.
|
article
|
| 44 |
A new in silico approach to revolutionize CNS PET tracer design and enhance translational success
|
Jackson, Isaac
|
|
|
122-123 |
S |
p. S24-S25
|
article
|
| 45 |
A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination
|
Wen, Xuejun
|
|
|
122-123 |
S |
p. S219-S220
|
article
|
| 46 |
A new phenylstannyl precursor for synthesizing [11C]UCB-J
|
Mori, Wakana
|
|
|
122-123 |
S |
p.
|
article
|
| 47 |
A new prospective CB2 receptor tracer based on a 18F labelled naphthyridine core: radiosynthesis and microPET imaging data
|
Pascali, Giancarlo
|
|
|
122-123 |
S |
p. S35
|
article
|
| 48 |
A new rhenium/technetium-99m complex bearing a quinazoline derivative and 2-picolylamine-N-acetic acid for EGFR imaging
|
Makrypidi, Konstantina
|
|
|
122-123 |
S |
p. S15
|
article
|
| 49 |
An improved separation scheme for 44Sc purification from proton irradiated calcium
|
Kurakina, Elena
|
|
|
122-123 |
S |
p. S92
|
article
|
| 50 |
An improved synthesis of [18F]VAT precursor for a one-step radiofluorination
|
Hu, Bao
|
|
|
122-123 |
S |
p. S85-S86
|
article
|
| 51 |
An interleukin-2 derived small peptide probe for CD25 targeted PET/CT imaging of activated T cells
|
Wang, Shuailiang
|
|
|
122-123 |
S |
p. S7
|
article
|
| 52 |
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks
|
Braband, Henrik
|
|
|
122-123 |
S |
p. S32-S33
|
article
|
| 53 |
A novel building block facilitates the synthesis of the 89Zr-Chelator DFO*
|
Feiner, Irene
|
|
|
122-123 |
S |
p.
|
article
|
| 54 |
A novel 18F-labeled reversible PET ligand for imaging monoacylglycerol lipase
|
Rong, Jian
|
|
|
122-123 |
S |
p.
|
article
|
| 55 |
A novel flexible pipetting-based platform for automated microvolume radiochemistry
|
Lu, Yingqing
|
|
|
122-123 |
S |
p. S58-S59
|
article
|
| 56 |
A novel fluorine-18 labeled P2Y12 receptor PET tracer for imaging of anti-inflammatory microglia
|
van der Wildt, Berend
|
|
|
122-123 |
S |
p. S108-S109
|
article
|
| 57 |
A novel PET ligand for imaging monoacylglycerol lipase in naïve and mouse models of Alzheimer’s disease
|
Rong, Jian
|
|
|
122-123 |
S |
p. S21
|
article
|
| 58 |
A Novel Prosthetic group, 4-[18F]Fluorophenylglyoxal for Protein Conjugation
|
Sadasivam, Pragalath
|
|
|
122-123 |
S |
p.
|
article
|
| 59 |
A Novel Purification Method to Improve the Chemical Purity of the 203Pb/212Pb Theranostic Pair
|
McNeil, Brooke
|
|
|
122-123 |
S |
p.
|
article
|
| 60 |
A novel radioiodinated probe for diagnosis of systemic amyloidosis based on thioflavin-T and Congo-red hybrid structure
|
Haratake, Yoshie
|
|
|
122-123 |
S |
p. S54-S55
|
article
|
| 61 |
A novel radioiodination method for the preparation of radiopharmaceuticals
|
Debnath, Shuvra
|
|
|
122-123 |
S |
p.
|
article
|
| 62 |
A novel radiotracer for imaging autotaxin: [18F]THPDPATX
|
Ebrahimi, Edris
|
|
|
122-123 |
S |
p. S186
|
article
|
| 63 |
A novel synthesis of [11C]FTIMD
|
Ishii, Hideki
|
|
|
122-123 |
S |
p.
|
article
|
| 64 |
A novel tetrahydrothienopyridine-based PET tracer for P2Y12 receptor imaging in the brain
|
Joseph, Emanuel
|
|
|
122-123 |
S |
p. S47
|
article
|
| 65 |
Antibody-based PET imaging of alpha-synuclein
|
Syvaenen, Stina
|
|
|
122-123 |
S |
p.
|
article
|
| 66 |
Antibody-based radioligands can distinguish between amyloid-beta subtypes beyond [11C]PiB-positive pathology
|
Syvaenen, Stina
|
|
|
122-123 |
S |
p.
|
article
|
| 67 |
Anti-EphA2 Minibody as a targeting antibody for the molecular imaging of fibrosarcoma tumors.
|
Birikorang, Peggy
|
|
|
122-123 |
S |
p.
|
article
|
| 68 |
Antigen-dependent inducible T cell reporter system for PET imaging of tumor specific antigens
|
Shin, Jaehoon
|
|
|
122-123 |
S |
p.
|
article
|
| 69 |
Antimicrobial peptide form native plant Erythrina crista-galli: a promising agent for diagnostic of infection foci
|
Osorio, Jessica
|
|
|
122-123 |
S |
p. S72-S73
|
article
|
| 70 |
A pilot study of [18F]AlF-HER2 Affibody in HER2-positive breast cancer patients
|
Guo, Xiaoyi
|
|
|
122-123 |
S |
p. S49
|
article
|
| 71 |
Application of ionic liquids for ring-opening of non-activated aziridines with [11C]CO2
|
Lindberg, Anton
|
|
|
122-123 |
S |
p. S28-S29
|
article
|
| 72 |
Application of Machine Learning Driven Computational Approaches for Novel CNS PET Tracer Development
|
Jackson, Isaac
|
|
|
122-123 |
S |
p.
|
article
|
| 73 |
Application of quaternary 1,4-diazabicyclo[2.2.2]octan (DABCO) salts for SN2 “minimalist” radiofluorination
|
Keuthen, Yannick
|
|
|
122-123 |
S |
p. S49
|
article
|
| 74 |
A Practical Production of Clinical Interesting Radiotracer [11C]UCB-J
|
Akula, Hari
|
|
|
122-123 |
S |
p.
|
article
|
| 75 |
Apramer-based synthesis of radiopharmaceuticals
|
Belugin, Kirill
|
|
|
122-123 |
S |
p. S179
|
article
|
| 76 |
A preclinical platform for the radiolabelling and in vivo monitoring of nanoparticles against Crohn’s Disease using live dynamic SPECT imaging
|
Karampelas, Theodoros
|
|
|
122-123 |
S |
p. S54-S55
|
article
|
| 77 |
A Preclinical Platform to Thoroughly Evaluate Novel Nanocomposites in the Full Spectrum of Drug Discovery (in vitro - in vivo - ex vivo) Towards Cancer Treatment
|
Sarpaki, Sophia
|
|
|
122-123 |
S |
p.
|
article
|
| 78 |
A Preliminary Study of the Ortho Effect on Radiofluorinations Using Aryl Sulfonium Salt Precursors
|
Zhang, Wei
|
|
|
122-123 |
S |
p.
|
article
|
| 79 |
A pretargeting approach to PET imaging with antibodies
|
Penawou, Pamela
|
|
|
122-123 |
S |
p. S59-S60
|
article
|
| 80 |
A pyrene-phthalocyanine conjugate for dual Cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy
|
lioret, Vivian
|
|
|
122-123 |
S |
p. S105-S106
|
article
|
| 81 |
A quest for simplicity: automated cassette-based purification of [61Cu]CuCl2 from solid Ni targets using a single time-list
|
Svedjehed, Johan
|
|
|
122-123 |
S |
p. S170
|
article
|
| 82 |
A rapid non-radiometric LC-MS/MS procedure for measuring the molar activity of cyclotron-produced [18F]fluoride
|
Ellin, Nicholas
|
|
|
122-123 |
S |
p.
|
article
|
| 83 |
Aryliodonium ylides as efficient precursors for astatine-211 labeling
|
Maingueneau, Clémence
|
|
|
122-123 |
S |
p. S174-S175
|
article
|
| 84 |
Arylpalladium complexes on solid supports for convenient last-step labelling of bioconjugates by [11C]CO
|
Hermange, Philippe
|
|
|
122-123 |
S |
p. S72
|
article
|
| 85 |
A side-by-side comparison of a monomer- versus a dimer-based 68Ga- and 177Lu-labeled FAP inhibitor for theranostic tumor stroma targeting
|
Läppchen, Tilman
|
|
|
122-123 |
S |
p.
|
article
|
| 86 |
A simple and fully automatic production of [18F]SMBT-1 using an All-in-One chemistry module
|
Ko, Nare
|
|
|
122-123 |
S |
p.
|
article
|
| 87 |
A simplified radiosynthesis of [18F]FMPEP for imaging CB1 receptors
|
Pees, Anna
|
|
|
122-123 |
S |
p. S83
|
article
|
| 88 |
A single-pot photo-induced reaction for zirconium-89 radioimmunoPET agents: an efficient approach for translation of radiolabeled antibodies for human use
|
Fong, Cyril
|
|
|
122-123 |
S |
p. S119-S120
|
article
|
| 89 |
Assessing the binding affinity of a 64Cu-labeled PSMA ligand in a micro physiological system
|
Sihver, Wiebke
|
|
|
122-123 |
S |
p.
|
article
|
| 90 |
Assessment for anti-fatigue effect of traditional oriental medicine via PET/CT
|
Park, Sun Mi
|
|
|
122-123 |
S |
p.
|
article
|
| 91 |
Assessment of [64Cu]Cu-FAP-2286 in immunocompetent mice bearing pancreatic ductal adenocarcinoma (PDAC) tumors
|
Seo, Jai Woong
|
|
|
122-123 |
S |
p.
|
article
|
| 92 |
Assessment of novel mesothelin specific human antibody VH-Fc fusion proteins-based PET agents
|
Cortez, Angel
|
|
|
122-123 |
S |
p.
|
article
|
| 93 |
Assessment of the influence of [18F]florastamin isomer on pharmacokinetic properties for prostate cancer diagnosis: preclinical comparison of biodistribution
|
Lee, Kyongkyu
|
|
|
122-123 |
S |
p.
|
article
|
| 94 |
A stable and robust production process of [18F]fluorodeprenyl-D2 using a cassette-type chemistry module
|
Ko, Nare
|
|
|
122-123 |
S |
p.
|
article
|
| 95 |
Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer
|
Poulie, Christian
|
|
|
122-123 |
S |
p. S60
|
article
|
| 96 |
A structure-activity relationship study of bimodal BODIPY-labeled PSMA-targeting bioconjugates
|
Stemler, Tobias
|
|
|
122-123 |
S |
p. S26-S27
|
article
|
| 97 |
A study to obtain a highly reproducible radiochemical yield (RCY) in the PSMA-11 radiolabeling
|
Iudicello, Antonella
|
|
|
122-123 |
S |
p. S142-S143
|
article
|
| 98 |
At-211-labeled L-tyrosine derivatives via neopentyl scaffold for targeted α-therapy
|
Kaizuka, Yuta
|
|
|
122-123 |
S |
p. S12-S13
|
article
|
| 99 |
A trifluoroborate (BF3) radioprosthetic group bearing FAP-targeting ligand for facile labeling with 18F via the 18F-19F isotope exchange reaction: synthesis, radiolabeling and in vivo evaluation
|
Bendre, Shreya
|
|
|
122-123 |
S |
p. S179-S180
|
article
|
| 100 |
Auger electrons in radionuclide therapy: Szilárd-Chalmers effect/hot atom chemistry during the targeted delivery of the isotopes
|
Szucs, Zoltán
|
|
|
122-123 |
S |
p.
|
article
|
| 101 |
Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies
|
Wawrowicz, Kamil
|
|
|
122-123 |
S |
p. S82-S83
|
article
|
| 102 |
Author Index
|
|
|
|
122-123 |
S |
p. S223-S235
|
article
|
| 103 |
AUTHOR INDEX
|
|
|
|
122-123 |
S |
p. S76-S81
|
article
|
| 104 |
Author Index
|
|
|
|
122-123 |
S |
p. S109-S114
|
article
|
| 105 |
Author Index
|
|
|
|
122-123 |
S |
p.
|
article
|
| 106 |
Automated cassette based synthesis of novel CB1 receptor tracer [18F]FPATPP produced via Ru-mediated 18F-fluorination
|
Rajala, Noora
|
|
|
122-123 |
S |
p.
|
article
|
| 107 |
Automated Clinical Radiosynthesis of [18F]-F-AraG using the Elixys FLEX/CHEM and PURE/FORM Synthesis System
|
Deyerle, Phillip
|
|
|
122-123 |
S |
p.
|
article
|
| 108 |
Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach
|
Wagner, Laurène
|
|
|
122-123 |
S |
p. S138-S139
|
article
|
| 109 |
Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model
|
Sahu, Sudeep
|
|
|
122-123 |
S |
p. S211
|
article
|
| 110 |
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter
|
Tu, Zhude
|
|
|
122-123 |
S |
p.
|
article
|
| 111 |
Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP
|
Sirindil, Fatih
|
|
|
122-123 |
S |
p. S137
|
article
|
| 112 |
Automated production of sodium [11C]butyrate
|
Pakula, Ryan
|
|
|
122-123 |
S |
p. S70-S71
|
article
|
| 113 |
Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC)
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S22-S23
|
article
|
| 114 |
Automated purification of radiometals produced by solid targets
|
Gongora-Servin, Benito
|
|
|
122-123 |
S |
p.
|
article
|
| 115 |
Automated radiolabeling of [68Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer
|
Chandrashekara, Hemantha Kumara
|
|
|
122-123 |
S |
p. S122-S123
|
article
|
| 116 |
Automated radiosyntheses of [18F]FMPEP-d
2 and [18F]MAGL-2102 for imaging the endocannabinoid system
|
Pees, Anna
|
|
|
122-123 |
S |
p.
|
article
|
| 117 |
Automated radiosynthesis of [18F]AlF-FAPI-42
|
Gröner, Benedikt
|
|
|
122-123 |
S |
p. S61-S62
|
article
|
| 118 |
Automated radiosynthesis of [18F]AV-45 using Elixys FLEX/CHEM and PURE/FORM synthesis system
|
Miller, William
|
|
|
122-123 |
S |
p. S132
|
article
|
| 119 |
Automated radiosynthesis of [18F]DOPA and [18F]FMT via copper-mediated nucleophilic F-18 Fluorination of arylstannanes on a new synthesizer
|
Nagachinta, Surasa
|
|
|
122-123 |
S |
p. S133-S134
|
article
|
| 120 |
Automated radiosynthesis of 6-[18F]F-L-DOPA from a boronic precursor on NEPTIS® module
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S129
|
article
|
| 121 |
Automated radiosynthesis of [18F]FMeNER-D2 using the simplified one-pot 18F-fluoromethylation.
|
Zhang, Ming-Rong
|
|
|
122-123 |
S |
p.
|
article
|
| 122 |
Automated radiosynthesis of meta-[18F]Fluorobenzylguanidine from a diaryliodonium salt precursor on NEPTIS® module
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S131
|
article
|
| 123 |
AUTOmated radiosynthesis of para-[131I]Iodo-L-phenylalanine on NEPTIS® module
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S130-S131
|
article
|
| 124 |
Automated radiosynthesis of the 18F-labeled BF2-chelated tetraaryl-azadipyrromethenes photosensitizer using isotopic exchange
|
Kawamura, Kazunori
|
|
|
122-123 |
S |
p. S81-S82
|
article
|
| 125 |
Automated synthesis and quality control of [18F]FFNP with GMP compliance
|
Kim, Dong Hyun
|
|
|
122-123 |
S |
p. S127-S128
|
article
|
| 126 |
Automated synthesis of D-[3-11C]Alanine on the Sofie Biosciences Elixys Flex/Chem
|
Simpson, Spenser
|
|
|
122-123 |
S |
p. S136-S137
|
article
|
| 127 |
Automated synthesis of 16-[131I]iodohexadecanoic acid: a lymphatic leakage tracer
|
Plhak, Elisabeth
|
|
|
122-123 |
S |
p. S59-S60
|
article
|
| 128 |
Automation of 4-[18F]fluorogabapentin radiosynthesis
|
Zhou, Yu-Peng
|
|
|
122-123 |
S |
p. S66
|
article
|
| 129 |
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne
|
Lee, Hsiaoju
|
|
|
122-123 |
S |
p.
|
article
|
| 130 |
Automation of two-step synthesis of [18F]FP-TMP using Trasis AllinOne
|
Lee, Hsiaoju
|
|
|
122-123 |
S |
p. S127
|
article
|
| 131 |
A versatile cassette-based adaptor for solid targets dissolution on commercial synthesis modules
|
Sciacca, Gabriele
|
|
|
122-123 |
S |
p. S46-S47
|
article
|
| 132 |
3-Aza-6-[18F]fluoro-isatoic anhydrides ([18F]AFIAs) - novel prosthetic groups for indirect radiolabeling
|
Willmann, Michael
|
|
|
122-123 |
S |
p. S28
|
article
|
| 133 |
131Ba as a promising SPECT-diagnostic match for 223/224Radium
|
Reissig, Falco
|
|
|
122-123 |
S |
p. S95
|
article
|
| 134 |
Behind the scenes of Ga-68-Trivehexin development: unique structure-activity relationships
|
Quigley, Neil
|
|
|
122-123 |
S |
p. S208-S209
|
article
|
| 135 |
8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor
|
Holschbach, Marcus
|
|
|
122-123 |
S |
p. S26-S27
|
article
|
| 136 |
Bifunctional [2.2.2]-cryptands: Selective and efficient chelators for the 203Pb/212Pb theranostic pair
|
McDonagh, Anthony
|
|
|
122-123 |
S |
p.
|
article
|
| 137 |
Binding of [64Cu]DOTATATE beyond the BBB
|
Andersen, Ida
|
|
|
122-123 |
S |
p. S172-S173
|
article
|
| 138 |
Bioconjugates labeled with Auger electron emitter: 135La, as potential therapeutic radiopharmaceutical
|
Walczak, Rafał
|
|
|
122-123 |
S |
p. S159
|
article
|
| 139 |
Bioconjugates of 103Pd/103mRh in-vivo generator for targeted Auger electron therapy
|
Gieraltowska, Joanna
|
|
|
122-123 |
S |
p. S188-S189
|
article
|
| 140 |
Biodistribution of a 67Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag)
|
Morais, Maurício
|
|
2014
|
122-123 |
S |
p. e44-e48
nvt p.
|
article
|
| 141 |
Biodistribution of [89Zr]DFO-Maleimide-VLP-1 in Wistar Rats by Positron Emission Tomography (PET)
|
Riffel, Kerry
|
|
|
122-123 |
S |
p.
|
article
|
| 142 |
Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging
|
Auchynnikava, Tatsiana
|
|
|
122-123 |
S |
p. S71-S72
|
article
|
| 143 |
Biological evaluation of 111In-clickable complexes for cancer theranostics
|
D’Onofrio, Alice
|
|
|
122-123 |
S |
p. S188
|
article
|
| 144 |
Bioorthogonal chemistry approach for theranostics of GRPR-expressing cancers
|
Gano, Lurdes
|
|
|
122-123 |
S |
p. S30
|
article
|
| 145 |
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation
|
Hoffmann, Chris
|
|
|
122-123 |
S |
p.
|
article
|
| 146 |
Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43
|
Pakula, Ryan
|
|
|
122-123 |
S |
p. S103
|
article
|
| 147 |
Bispidine - One chelator to bind lutetium-177 and actinium-225
|
Brühlmann, Santiago
|
|
|
122-123 |
S |
p.
|
article
|
| 148 |
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies
|
Wünsche, Adrian
|
|
|
122-123 |
S |
p. S74-S75
|
article
|
| 149 |
Blood–brain barrier penetrating peptide-based radioligands targeting the EGFR:EGFRvIII receptors
|
Schuderer, Franziska
|
|
|
122-123 |
S |
p. S71-S72
|
article
|
| 150 |
Blood-brain barrier permeable antibodies for brain imaging
|
van den Broek, Sara Lopes
|
|
|
122-123 |
S |
p.
|
article
|
| 151 |
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts
|
Garcia, Raul Perez
|
|
|
122-123 |
S |
p. S84
|
article
|
| 152 |
Brain energetics by biomedical modalities
|
Tiwari, Anjani
|
|
|
122-123 |
S |
p. S108
|
article
|
| 153 |
Bringing personalized medicine to the next level: RANKL immuno-PET imaging using [64Cu]Cu-NOTA-anti-RANKL-Fab fragments
|
Dewulf, Jonatan
|
|
|
122-123 |
S |
p. S184-S185
|
article
|
| 154 |
Bucherer-Bergs multicomponent reaction with [11C]CO2, a facile and divergent synthesis of 11C-labelled hydantoins
|
van der Aa, Frank
|
|
|
122-123 |
S |
p. S75
|
article
|
| 155 |
Cancer theranostics using radiolabelled PARP inhibitors
|
Ferrat, Mélodie
|
|
|
122-123 |
S |
p.
|
article
|
| 156 |
Can the Radiochemical Purity of 225Ac-Labeled Compounds be Accurately Assessed by Radio-TLC Alone?
|
Wacker, Anja
|
|
|
122-123 |
S |
p.
|
article
|
| 157 |
Capsular reformulation of the PET radiopharmaceutical [18F]FTHA for oral administration
|
Moerlein, Stephen
|
|
|
122-123 |
S |
p. S144
|
article
|
| 158 |
Carbamoyl fluoride as a potential new tag for 18F-labeling
|
Bonnefoy, Clémence
|
|
|
122-123 |
S |
p. S77-S78
|
article
|
| 159 |
Carbasugars synthesis and derivatization: a new labelling strategy with 99mTc for infection diagnostic agents
|
Gretter, Mariella Terán
|
|
|
122-123 |
S |
p. S40-S41
|
article
|
| 160 |
Carbon-11 carboxylation of trialkoxysilane and trimethylsilane derivatives using [11C]CO2
|
Bongarzone, Salvatore
|
|
|
122-123 |
S |
p. S68
|
article
|
| 161 |
Carbon-11 labelled isocyanides: new versatile building blocks to access novel PET tracers
|
Bonnemaire, Coralie
|
|
|
122-123 |
S |
p. S27-S28
|
article
|
| 162 |
Carbon-11 Labelling of Benzenesulfonamide Analogues as Novel Radiotracers to Visualize the Pore-forming Activity of Perforin
|
Zhang, Bo
|
|
|
122-123 |
S |
p.
|
article
|
| 163 |
Cationic pH-responsive albumin binding ligands (ABLs) for enhanced cancer-specific theranostics
|
Lee, Jeong-Seob
|
|
|
122-123 |
S |
p.
|
article
|
| 164 |
11C-Carbonylation using TracerLab FX Synthesis modules
|
Shao, Xia
|
|
|
122-123 |
S |
p. S136
|
article
|
| 165 |
[11C]Carboxylated tetrazines for facile labeling of trans-cyclooctene-functionalized macromolecules
|
Vázquez, Rocío García
|
|
|
122-123 |
S |
p. S71-S72
|
article
|
| 166 |
11C-Carboxylation via organic photoredox-catalyzed isotopic exchange
|
Munch, Maxime
|
|
|
122-123 |
S |
p. S29
|
article
|
| 167 |
CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts
|
Bidkar, Anil
|
|
|
122-123 |
S |
p. S31
|
article
|
| 168 |
CD133-Targeted Radioimmunotherapy of Small Cell Lung Cancer
|
Sebastiano, Joni
|
|
|
122-123 |
S |
p.
|
article
|
| 169 |
Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents?
|
Müller, Cristina
|
|
|
122-123 |
S |
p. S26
|
article
|
| 170 |
Centralized GMP production of [90Y]Y-PentixaTher for clinical trials
|
Berroteran-Infante, Neydher
|
|
|
122-123 |
S |
p. S121
|
article
|
| 171 |
Cerenkov Luminescence Signal Enhancement using Hyperbolic Metamaterials as a Multi-modal Imaging Probe
|
Boykoff, Natalie
|
|
|
122-123 |
S |
p.
|
article
|
| 172 |
cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity
|
Pisaneschi, Federica
|
|
|
122-123 |
S |
p.
|
article
|
| 173 |
11C-guanylated histamine for PET cardiac imaging
|
Mhanna, Karim
|
|
|
122-123 |
S |
p.
|
article
|
| 174 |
C-H activation: optimisation of palladium mediated 11C methylation
|
Ariztia, Julen
|
|
|
122-123 |
S |
p. S70
|
article
|
| 175 |
Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain
|
Zheng, Ming-Qiang
|
|
|
122-123 |
S |
p. S5
|
article
|
| 176 |
Characterization of new FSHβ-derived peptide probes for the validation of FSHR as a new prognostic and predictive biomarker in primary and metastatic cancers
|
Carpanese, Debora
|
|
|
122-123 |
S |
p. S89
|
article
|
| 177 |
Chelation of Manganese - 52 for development of long-lived PET radiopharmaceuticals
|
Omweri, James
|
|
|
122-123 |
S |
p.
|
article
|
| 178 |
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-64
|
Krutzek, Fabian
|
|
|
122-123 |
S |
p. S38
|
article
|
| 179 |
Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy
|
Hao, Guiyang
|
|
|
122-123 |
S |
p.
|
article
|
| 180 |
Chemoenzymatic Synthesis of Fluorine-18-Labelled Disaccharides Used for PET Imaging of Bacteria Infection
|
Sorlin, Alexandre
|
|
|
122-123 |
S |
p.
|
article
|
| 181 |
Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer
|
Rao, Yi
|
|
|
122-123 |
S |
p. S210-S211
|
article
|
| 182 |
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues
|
Donat, Cornelius
|
|
|
122-123 |
S |
p. S220
|
article
|
| 183 |
Chromophore-conjugated NCS-activated NODAGA is a versatile tool for quantitative prediction of protein-chelator conjugation for 64Cu-immunoPET
|
Seyfried, Dominik
|
|
|
122-123 |
S |
p. S10-S11
|
article
|
| 184 |
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics
|
Cools, Romy
|
|
|
122-123 |
S |
p.
|
article
|
| 185 |
11C-labelled oxadiazoles via 11C-labelled acyl amidines through a one-pot, two-step reaction
|
Rydfjord, Jonas
|
|
|
122-123 |
S |
p. S74
|
article
|
| 186 |
Click-cleavable 111In/177Lu-labeled DOTA-TCO-trastuzumab for imaging and therapy of breast cancer
|
de Roode, Kim
|
|
|
122-123 |
S |
p. S16
|
article
|
| 187 |
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study
|
Park, Jun Hyung
|
|
|
122-123 |
S |
p.
|
article
|
| 188 |
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors
|
Orlova, Anna
|
|
|
122-123 |
S |
p. S58
|
article
|
| 189 |
11C-MePro PET/CT Imaging in Normal Volunteers: Initial Evaluation of PET-based Human Biodistribution
|
Yamazaki, Kana
|
|
|
122-123 |
S |
p.
|
article
|
| 190 |
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma
|
Laursen, Vigga
|
|
|
122-123 |
S |
p.
|
article
|
| 191 |
Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer
|
Wen, Xuejun
|
|
|
122-123 |
S |
p. S33
|
article
|
| 192 |
Combining Positron Emission Tomography and Hyperpolarized Magnetic Resonance to Interrogate Prostate Cancer Metabolism
|
Enriquez, Jose
|
|
|
122-123 |
S |
p.
|
article
|
| 193 |
Come up smelling of roses – Using a real-time radioligand assay to elucidate PD-L1 binding of different ligand classes
|
Donat, Cornelius
|
|
|
122-123 |
S |
p.
|
article
|
| 194 |
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy
|
Gouard, S.
|
|
2014
|
122-123 |
S |
p. e30-e35
nvt p.
|
article
|
| 195 |
Comparative evaluation by SPECT and PET imaging of two immuno-pre-targeting systems in an in vivo model of triple negative breast tumours with anti-EGFR antibodies
|
Briat, Arnaud
|
|
|
122-123 |
S |
p. S204-S205
|
article
|
| 196 |
Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours
|
Tawate, Megha
|
|
|
122-123 |
S |
p. S213-S214
|
article
|
| 197 |
Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74
|
Tran, Thuy
|
|
|
122-123 |
S |
p. S216-S217
|
article
|
| 198 |
Comparative in vivo PET/CT, biodistribution, and excretion study of Cu-64 labeled Polypropylene (PP) nanoplastics via various administration routes in mice
|
Kwon, Mihye
|
|
|
122-123 |
S |
p.
|
article
|
| 199 |
Comparing the day-to-day production of [68Ga]Ga-PSMA-11 using Locametz and Illuccix Kits
|
Wang, Ivan
|
|
|
122-123 |
S |
p.
|
article
|
| 200 |
Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models
|
Sihver, Wiebke
|
|
|
122-123 |
S |
p. S212-S213
|
article
|
| 201 |
Comparison of biodistribution according to administration route for the development of liposome therapeutics
|
Yoo, Ran Ji
|
|
|
122-123 |
S |
p. S165
|
article
|
| 202 |
Comparison of [11C] and [18F] labelled D-amino acid tracers for imaging of bacterial infection
|
Lopez-Alvarez, Marina
|
|
|
122-123 |
S |
p.
|
article
|
| 203 |
Comparison of cyclotron produced manganese-52 from natural chromium and vanadium targets
|
Nielsen, Karin Michaelsen
|
|
|
122-123 |
S |
p. S171-S172
|
article
|
| 204 |
Comparison of DOTA, NODAGA and 15-5 macrocycles as chelators for 64Cu-labelling of immunoconjugates
|
Maisonial-Besset, Aurélie
|
|
|
122-123 |
S |
p. S153-S154
|
article
|
| 205 |
Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma
|
Pun, Michael
|
|
|
122-123 |
S |
p. S61
|
article
|
| 206 |
Comparison of [18F]FEOBV, [3H]VAT, [3H]MK-6884 and [3H]JNJ-64511070 for imaging Alzheimer’s disease
|
d’Orchymont, Faustine
|
|
|
122-123 |
S |
p.
|
article
|
| 207 |
Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor
|
Donat, Cornelius
|
|
|
122-123 |
S |
p.
|
article
|
| 208 |
Comparison of [68Ga]Ga precursors for blood cell radiolabeling
|
Bouvry, Christelle
|
|
|
122-123 |
S |
p. S57
|
article
|
| 209 |
Comparison of the Biodistribution of [18F]FNP-59 and its Esters
|
Brooks, Allen
|
|
|
122-123 |
S |
p.
|
article
|
| 210 |
Comparison of the syntheses of 18F-labelled norepinerphrine transporter tracer [18F]NS12137 using in-house built device and Trasis AllinOne
|
Rajala, Noora
|
|
|
122-123 |
S |
p.
|
article
|
| 211 |
Comparison of two cyclen-based phosphonates for development of bone-seeking lutetium-177 radiopharmaceuticals
|
Mitrofanov, Iurii
|
|
|
122-123 |
S |
p. S70-S71
|
article
|
| 212 |
Comparison of Voxelized Monte Carlo and OLINDA Dosimetry Methods Towards 67Cu-LLP2A Therapy from 64Cu-LLP2A PET/CT Imaging Data
|
Bellavia, Michael
|
|
|
122-123 |
S |
p.
|
article
|
| 213 |
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer
|
Ho, Van
|
|
|
122-123 |
S |
p.
|
article
|
| 214 |
Complexation of [186Re][Re(CO)3]+ and [99mTc][Tc(CO)3]+ cores with TACN-based chelators
|
Hoerres, Rebecca
|
|
|
122-123 |
S |
p.
|
article
|
| 215 |
Computational design, synthesis and radiolabelling of a novel octacoordinate chelator for 89Zr
|
Klingler, Simon
|
|
|
122-123 |
S |
p. S45-S46
|
article
|
| 216 |
Conception of Nanoparticles as Diagnostic Agents
|
Mignet, Nathalie
|
|
|
122-123 |
S |
p. S2-S3
|
article
|
| 217 |
CONTENTS
|
|
|
|
122-123 |
S |
p. iii
|
article
|
| 218 |
Contents
|
|
|
2014
|
122-123 |
S |
p. IBC-
1 p.
|
article
|
| 219 |
CONTENTS
|
|
|
|
122-123 |
S |
p.
|
article
|
| 220 |
Convenient preparation of 18F-labeled human insulin by Pd-catalyzed S-arylation
|
Humpert, Swen
|
|
|
122-123 |
S |
p. S116-S117
|
article
|
| 221 |
Copper-61 as an alternative to Gallium-68 for radiopharmaceutical production: feasibility study and scale-up for clinical doses
|
Fonseca, Alexandra
|
|
|
122-123 |
S |
p. S21-S22
|
article
|
| 222 |
Copper catalyzed radiobromination of boronic pinacol esters: utility in PARP inhibitor synthesis
|
Mixdorf, Jason
|
|
|
122-123 |
S |
p. S175
|
article
|
| 223 |
Copper-free click labeling with the [99mTc]Tc-tricarbonyl-core using DACN derivatives
|
Mamat, Constantin
|
|
|
122-123 |
S |
p. S37
|
article
|
| 224 |
Copper-61 from liquid targets: optimized purification for GMP labelling
|
Fonseca, Alexandra
|
|
|
122-123 |
S |
p. S98-S99
|
article
|
| 225 |
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study
|
Bolik, Kim-Viktoria
|
|
|
122-123 |
S |
p. S35-S36
|
article
|
| 226 |
Copper mediated radiocyanation of aryl halides
|
Sharninghausen, Liam
|
|
|
122-123 |
S |
p. S29-S30
|
article
|
| 227 |
Corrole radiolabelling with 68Ga, 64Cu and 67Cu - a novel approach for theranostic applications in cancer
|
Ekaney, Thomas Kolle
|
|
|
122-123 |
S |
p.
|
article
|
| 228 |
Covalent Modification of Black Phosphorus Nanosheets with 89-Zirconium
|
Shen, Jieting
|
|
|
122-123 |
S |
p.
|
article
|
| 229 |
11C-Radiolabeling of α-amino acids via aldehyde-promoted isotopic exchange reaction
|
Munch, Maxime
|
|
|
122-123 |
S |
p. S29
|
article
|
| 230 |
C(sp3)-H functionalization for access to [11C]amino acids
|
Edgar, Fraser
|
|
|
122-123 |
S |
p. S68-S69
|
article
|
| 231 |
64Cu-DOTHA2-PSMA, a novel theranostic agent for prostate cancer and its preclinical animal evaluation
|
Milot, Marie-Christine
|
|
|
122-123 |
S |
p. S105
|
article
|
| 232 |
Cu-64 heterodimers targeting GRPR: PSMA expressing cells: in vitro and in vivo investigations
|
Chambers, Claudia
|
|
|
122-123 |
S |
p. S8
|
article
|
| 233 |
64Cu-labeled fucoidan nanoparticles for non-invasive PET/CT tumor imaging
|
Kim, Kyungwon
|
|
|
122-123 |
S |
p.
|
article
|
| 234 |
64Cu-labeled panitumumab for PET imaging of EGFR+ non-small cell lung cancer: Subcutaneous and metastatic mouse models
|
Wuest, Frank
|
|
|
122-123 |
S |
p.
|
article
|
| 235 |
64Cu-labeled TCP-1 probe for PET imaging of colorectal cancer
|
Li, Feng
|
|
|
122-123 |
S |
p.
|
article
|
| 236 |
64Cu-Lazarus: bringing our [64Cu]CuCl2 manufacturing system back to life
|
Stimson, Damion
|
|
|
122-123 |
S |
p.
|
article
|
| 237 |
Cu-mediated 18F-radiofluorination of various stannylated FDOPA precursors – what is feasible?
|
Kniess, Torsten
|
|
|
122-123 |
S |
p.
|
article
|
| 238 |
64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: Targetry, radiochemistry and PET imaging for utility assessment
|
Nelson, Bryce
|
|
|
122-123 |
S |
p.
|
article
|
| 239 |
Curcumin-based 68Ga-radiotraces: radiolabeling strategies and bifunctional chelator approach
|
Mari, Matteo
|
|
|
122-123 |
S |
p. S69
|
article
|
| 240 |
Current developments in the production of actinium-225 from thorium-229
|
Benny, Paul
|
|
|
122-123 |
S |
p. S42
|
article
|
| 241 |
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor
|
Högnäsbacka, Antonia
|
|
|
122-123 |
S |
p.
|
article
|
| 242 |
Cyclic [68Ga] and [18F]AlF-labeled peptides for specific detection of human angiotensin-converting enzyme 2
|
Wilson, David
|
|
|
122-123 |
S |
p. S64-S65
|
article
|
| 243 |
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes
|
Jaworski, Carolin
|
|
|
122-123 |
S |
p.
|
article
|
| 244 |
Cyclotron-based Production of Lanthanum-133 with High Radionuclidic Purity for Theranostic Purposes
|
Brühlmann, Santiago
|
|
|
122-123 |
S |
p.
|
article
|
| 245 |
Cyclotron Production of Copper-67: Exploring the limits
|
Brühlmann, Santiago
|
|
|
122-123 |
S |
p.
|
article
|
| 246 |
Cyclotron production of gallium-68 from liquid target: routine production of 68Ga-labelled radiotracers
|
Uhlending, Antje
|
|
|
122-123 |
S |
p. S151
|
article
|
| 247 |
Cyclotron-production of manganese-52 for multi-modal imaging applications
|
Boschi, Alessandra
|
|
|
122-123 |
S |
p. S46
|
article
|
| 248 |
Cyclotron-production of Mn-52: an update on the METRICS project
|
Martini, Petra
|
|
|
122-123 |
S |
p. S169-S170
|
article
|
| 249 |
Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target
|
Nelson, Bryce
|
|
|
122-123 |
S |
p. S171
|
article
|
| 250 |
Cyclotron production of the theranostic pair 133/135La for nuclear medicine
|
Nelson, Bryce
|
|
|
122-123 |
S |
p. S2-S3
|
article
|
| 251 |
Cytotoxicity of the bimodal [224Ra]RaCl2 and [212Pb]Pb-TCMC-TP-3 solution in a multicellular tumor spheroid model of osteosarcoma
|
Tornes, Anna Julie
|
|
|
122-123 |
S |
p. S15-S16
|
article
|
| 252 |
Delayed 64Cu-DOTA-Rituximab PET image generation for dosimetry using paired image-to-image translation
|
Kim, Kangsan
|
|
|
122-123 |
S |
p.
|
article
|
| 253 |
Demonstrating peptide based nanoconstructs as emerging theranostic biomolecules
|
Khan, Irfan
|
|
|
122-123 |
S |
p. S87-S88
|
article
|
| 254 |
Demonstration of intracellular pH-weighting PET imaging using a new-type PET probe responsible for monoacylglycerol lipase activity in the brain
|
Yamasaki, Tomoteru
|
|
|
122-123 |
S |
p. S112-S113
|
article
|
| 255 |
De novo design of alpha-synuclein small molecule PET tracers
|
Korat, Spela
|
|
|
122-123 |
S |
p. S97
|
article
|
| 256 |
De novo design of lead structures for P2Y12 receptor tracer development using in silico methods
|
Stéen, E. Johanna
|
|
|
122-123 |
S |
p. S105-S106
|
article
|
| 257 |
Density functional theory experiments offer insight into properties of the Sc-HOPO complex
|
Phipps, Michael
|
|
|
122-123 |
S |
p. S71
|
article
|
| 258 |
Design and evaluation of new 99mTc/188Re-labeled TSPO-binding ligands for cancer theragnostic
|
Lee, Kyeongyang
|
|
|
122-123 |
S |
p.
|
article
|
| 259 |
Design and synthesis of a new bifunctional chelating agent for 18F-Al/177Lu radiolabelling: theranostic approach
|
Wagner, Laurène
|
|
|
122-123 |
S |
p. S12-S13
|
article
|
| 260 |
Design and synthesis of fluorinated pyrazolidine-3,5-dione derivatives as potential P2Y12 receptor PET tracers
|
Stéen, E. Johanna
|
|
|
122-123 |
S |
p.
|
article
|
| 261 |
Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations
|
Judmann, Benedikt
|
|
|
122-123 |
S |
p.
|
article
|
| 262 |
Design and synthesis of novel heptadentate chelates for 89Zr-radiolabelling of antibodies
|
Guillou, Amaury
|
|
|
122-123 |
S |
p. S7
|
article
|
| 263 |
Designing and validating the nested neutron spectrometer using for accelerator-based neutron source: Monte Carlo code and artificial intelligence algorithm
|
Tuan, Hoang
|
|
|
122-123 |
S |
p. S73
|
article
|
| 264 |
Design space approach to optimise the [68Ga]Ga-Pentixafor radiolabelling process
|
Kaufmann, Jens
|
|
|
122-123 |
S |
p. S60
|
article
|
| 265 |
Design, synthesis and biological evaluation of a small-molecule PET imaging agent for imaging PD-L1 expression
|
Xu, Liang
|
|
|
122-123 |
S |
p.
|
article
|
| 266 |
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors
|
Millard, Marlon
|
|
|
122-123 |
S |
p.
|
article
|
| 267 |
Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase
|
Pu, Yinglan
|
|
|
122-123 |
S |
p.
|
article
|
| 268 |
Detecting EGFR expression in bladder cancer using [89Zr]Zr-DFO-Panitumumab immunoPET imaging
|
Hoang, Tran
|
|
|
122-123 |
S |
p. S194
|
article
|
| 269 |
Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133
|
Blei, Magdalena
|
|
|
122-123 |
S |
p.
|
article
|
| 270 |
Determination of 2-chloro-2-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and glucose in [18F]Fluorodeoxyglucose by capillary electrophoresis
|
Antuganova, Yulia
|
|
|
122-123 |
S |
p. S80
|
article
|
| 271 |
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production
|
Ta, Robert
|
|
|
122-123 |
S |
p.
|
article
|
| 272 |
Development and application of a fully automated multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis
|
Cui, Fang-Bo
|
|
|
122-123 |
S |
p.
|
article
|
| 273 |
Development and biological evaluation of 18F-labeled adenosine-A1-receptor partial agonists
|
Evcüman, Sibel
|
|
|
122-123 |
S |
p. S9
|
article
|
| 274 |
Development and evaluation of fully automated F-18 cromolyn diethyl ester labeling via multi step reaction as potential therapeutics for Alzheimer’s Disease for brain PET imaging
|
Moon, Sung-Hyun
|
|
|
122-123 |
S |
p.
|
article
|
| 275 |
Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A9
|
Steiner, Simon
|
|
|
122-123 |
S |
p. S44-S45
|
article
|
| 276 |
Development and evaluation of novel TSPO PET tracers with low binding sensitivity to human single nucleotide polymorphism rs6971
|
Beaino, Wissam
|
|
|
122-123 |
S |
p.
|
article
|
| 277 |
Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging
|
Adhikari, Karuna
|
|
|
122-123 |
S |
p. S176
|
article
|
| 278 |
Development and exploration of bifunctional chelating ligands for mercury-197m/g
|
Randhawa, Parmissa
|
|
|
122-123 |
S |
p. S13-S14
|
article
|
| 279 |
Development and First-in-Man Study of a Novel Tetrapeptidic CCK-2R-Targeted Compound with Improved Metabolic Stability and Pharmacokinetics
|
Günther, Thomas
|
|
|
122-123 |
S |
p.
|
article
|
| 280 |
Development and initial evaluation of two [99mTc]Tc complexes derived from a fibroblast activating protein (FAP) inhibitor
|
Decuadra, Paula
|
|
|
122-123 |
S |
p. S39-S40
|
article
|
| 281 |
Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma
|
Métivier, Cassandra
|
|
|
122-123 |
S |
p. S203-S204
|
article
|
| 282 |
Development and in vivo Evaluation of a Novel 18F-labeled Aromatase Inhibitor PET Radiotracer in Rodent Models for Cancer
|
Li, Songye
|
|
|
122-123 |
S |
p.
|
article
|
| 283 |
Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression
|
Cools, Romy
|
|
|
122-123 |
S |
p. S93-S94
|
article
|
| 284 |
Development and pre-clinical evaluation of new 64Cu-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors
|
Alhokbany, Norah
|
|
|
122-123 |
S |
p. S74
|
article
|
| 285 |
Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform
|
Martin, Sebastian
|
|
|
122-123 |
S |
p. S41
|
article
|
| 286 |
Development and preliminary evaluation of the fluorine-18 labeled benzamido-dihydroindene derivative [18F]FBAIN as a potential radiotracer for PET imaging of the chemokine receptor CXCR5
|
Lindemann, Marcel
|
|
|
122-123 |
S |
p. S200-S201
|
article
|
| 287 |
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor
|
Vercouillie, Johnny
|
|
|
122-123 |
S |
p.
|
article
|
| 288 |
Development and Radiosynthesis of [11C]MODAG-005 for in vivo Imaging of alpha-synuclein Pathology
|
Maurer, Andreas
|
|
|
122-123 |
S |
p.
|
article
|
| 289 |
Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module
|
Joyard, Yoann
|
|
|
122-123 |
S |
p. S128
|
article
|
| 290 |
Development of a Candidate PET Radioligand for Receptor Interacting Protein 1 Kinase (RIPK1) and Evaluation in Healthy Monkey
|
Jana, Susovan
|
|
|
122-123 |
S |
p.
|
article
|
| 291 |
Development of a 64Cu-labeled immuno-PET probe for imaging Sialyl Lewis X in breast cancer
|
Kaur, Jatinder
|
|
|
122-123 |
S |
p. S221
|
article
|
| 292 |
Development of a dual imaging probe for bimodal PET/ two-photon NIRF imaging
|
Jouad, Kamal
|
|
|
122-123 |
S |
p. S167-S168
|
article
|
| 293 |
Development of a [18F]PD-L1 radiotracer to profile cancer patient response to immunotherapy
|
Zecca, Henry
|
|
|
122-123 |
S |
p. S189
|
article
|
| 294 |
Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging
|
Perrio, Cecile
|
|
|
122-123 |
S |
p. S84
|
article
|
| 295 |
Development of a highly specific 18F-labeled benzimidazolone-based sigma-2 receptor radioligand for brain tumor imaging
|
Huang, Henry
|
|
|
122-123 |
S |
p.
|
article
|
| 296 |
Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging
|
Battisti, Umberto
|
|
|
122-123 |
S |
p. S178-S179
|
article
|
| 297 |
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC
|
Hooijman, Eline
|
|
|
122-123 |
S |
p. S22-S23
|
article
|
| 298 |
Development of a 99mTc-NTP 15-5 kit for an early clinical trial
|
Sophie, Levesque
|
|
|
122-123 |
S |
p. S145
|
article
|
| 299 |
Development of a [99mTc]Tc-PVP nanogel for controlled release of 5-FU
|
Ges-Naranjo, Adrian
|
|
|
122-123 |
S |
p. S84-S85
|
article
|
| 300 |
Development of an effective electro-amalgamation technique to debulk Eu(III) from Eu(III)/Tb(III) mixtures: Towards future application in the separation of 155Tb from alpha-irradiated 153Eu
|
Serasinghe, Madhushan
|
|
|
122-123 |
S |
p.
|
article
|
| 301 |
Development of a new class of Mn(II) complexes for MRI applications
|
Boschi, Alessandra
|
|
|
122-123 |
S |
p. S69-S70
|
article
|
| 302 |
Development of a New 64Cu-Semicarbazone Complex: Potential Theragnostic Radiopharmaceutical for Hypoxic Tumor
|
Alhokbany, Norah
|
|
|
122-123 |
S |
p.
|
article
|
| 303 |
Development of a new reagent for 18F-trifluoroethylation of secondary amine
|
Choi, Ji Young
|
|
|
122-123 |
S |
p.
|
article
|
| 304 |
Development of an 18F-labeled MutT Homolog 1 (MTH1) radiotracer ([18F]WC-7-73): synthesis, radiosynthesis and evaluation
|
Chu, Wenhua
|
|
|
122-123 |
S |
p.
|
article
|
| 305 |
Development of an in-house 188W/188Re generator for rhenium-188 production and radiolabelling studies
|
Melis, Diana
|
|
|
122-123 |
S |
p. S38
|
article
|
| 306 |
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging
|
Chen, Jiahui
|
|
|
122-123 |
S |
p.
|
article
|
| 307 |
Development of a novel carbon-11 radiotracer for brain PET imaging of sulfonylurea receptors 1
|
Caillé, Fabien
|
|
|
122-123 |
S |
p. S33-S34
|
article
|
| 308 |
Development of a novel 68Ga-labeled benzo[h]quinoline-based FAP-targeted PET tracer: Synthesis, preclinical evaluation, and comparison with [68Ga]Ga-FAPI-04
|
Lin, Kuo-Shyan
|
|
|
122-123 |
S |
p.
|
article
|
| 309 |
Development of a novel PET ligand for imaging AMPA receptor
|
Chen, Jiahui
|
|
|
122-123 |
S |
p.
|
article
|
| 310 |
Development of a novel PET tracer for imaging of γ-8 dependent transmembrane AMPA receptor regulatory protein
|
Yu, Qingzhen
|
|
|
122-123 |
S |
p. S66-S68
|
article
|
| 311 |
Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold
|
He, Yingfang
|
|
|
122-123 |
S |
p. S5-S6
|
article
|
| 312 |
Development of Approaches for High-Throughput Experimentation in Radiochemistry
|
Webb, Eric
|
|
|
122-123 |
S |
p.
|
article
|
| 313 |
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy
|
Payne, Rachel
|
|
|
122-123 |
S |
p.
|
article
|
| 314 |
Development of a radiolabeled self-assembled nanoparticle as an imaging probe for CD44-expressing tumors
|
Tanaka, Toshie
|
|
|
122-123 |
S |
p. S83-S84
|
article
|
| 315 |
Development of a radiotheranostics agent with albumin binder aiming to increase the therapeutic effects for At-211 labeled RGD peptide
|
Echigo, Hiroaki
|
|
|
122-123 |
S |
p.
|
article
|
| 316 |
Development of a (+)RESCA-triaryl phosphine for in vitro radiolabeling using the Staudinger ligation
|
Biti, Anisa
|
|
|
122-123 |
S |
p.
|
article
|
| 317 |
Development of a small-molecule CXCR3 PET radiotracer for atherosclerosis imaging in live animals
|
Alluri, Santosh Reddy
|
|
|
122-123 |
S |
p. S17
|
article
|
| 318 |
Development of a stabilized GRPR antagonist for targeted cancer theranostics
|
Abouzayed, Ayman
|
|
|
122-123 |
S |
p. S24
|
article
|
| 319 |
Development of a stable peptide-based PET tracer for detecting CD133-expressing cancer cells
|
Hu, Kuan
|
|
|
122-123 |
S |
p. S195
|
article
|
| 320 |
Development of Astatine-211 labeling reaction using aryliodonium ylide
|
Ogawa, Mikako
|
|
|
122-123 |
S |
p.
|
article
|
| 321 |
Development of automatic synthesis method for [18F]Fluoromethyl-PBR28 using two synthesizer
|
Cho, Yong-Hyun
|
|
|
122-123 |
S |
p. S123
|
article
|
| 322 |
Development of bispecific theranostic ligand targeting the prostate specific membrane antigen (PSMA) and gastrin releasing peptide (GRPR) receptor
|
Bouzioti, Danai
|
|
|
122-123 |
S |
p. S29-S30
|
article
|
| 323 |
Development of BODIPY-Tetrazines as Pretargeted Bimodal Fluorescent-Radioactive Tracers
|
Herth, Matthias
|
|
|
122-123 |
S |
p.
|
article
|
| 324 |
Development of CD44-targeted 64Cu-labeled peptide for diagnosis of cancer stem cells
|
Eom, Sairan
|
|
|
122-123 |
S |
p.
|
article
|
| 325 |
Development of C-terminal modified long-acting DOTA-JR11 analogs for optimized treatment of NETs
|
Handula, Maryana
|
|
|
122-123 |
S |
p.
|
article
|
| 326 |
Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer
|
Müller, Marius
|
|
|
122-123 |
S |
p. S206
|
article
|
| 327 |
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer
|
Seo, Hye Yeon
|
|
|
122-123 |
S |
p. S61
|
article
|
| 328 |
Development of discoidal phospholipid bilayer nanoparticles with styrene maleic acid copolymer for diagnosis and therapy of intractable cancers
|
Munekane, Masayuki
|
|
|
122-123 |
S |
p. S83
|
article
|
| 329 |
Development of FAP targeted radiopharmaceuticals
|
Xu, Mengxin
|
|
|
122-123 |
S |
p. S221
|
article
|
| 330 |
Development of [18F]Fluoromannitol, a Novel Radiopharmaceutical for Infection Imaging
|
Simpson, Spenser
|
|
|
122-123 |
S |
p.
|
article
|
| 331 |
Development of [18F]fluoro-4-(vinylsulfonyl)benzene for chemoselective cysteine radiofunctionalization of peptides
|
McDaniel, James
|
|
|
122-123 |
S |
p. S75-S76
|
article
|
| 332 |
Development of finely tuned liposome nanoplatform for effective macrophage targeting and depletion
|
Choi, Tae Hyeon
|
|
|
122-123 |
S |
p.
|
article
|
| 333 |
Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging
|
Müller, Marius
|
|
|
122-123 |
S |
p.
|
article
|
| 334 |
Development of 18F-labeled agonist for imaging STING in the tumor microenvironment
|
Liu, Huanhuan
|
|
|
122-123 |
S |
p. S19-S20
|
article
|
| 335 |
Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier
|
Shalgunov, Vladimir
|
|
|
122-123 |
S |
p. S103-S104
|
article
|
| 336 |
Development of 18F-labeled tracer for noninvasive PET imaging of the STING expression in tumor microenvironment
|
Fang, Jianyang
|
|
|
122-123 |
S |
p. S187-S188
|
article
|
| 337 |
Development of 18F-Labelled CXCR4-Targeted Peptide Radiopharmaceuticals Through Strain-Promoted Click Chemistry
|
Mason, Julia
|
|
|
122-123 |
S |
p.
|
article
|
| 338 |
Development of freeze-dried kit for one-step expeditious preparation of [99mTc]Tc-PSMA-T4
|
Wojdowska, Wioletta
|
|
|
122-123 |
S |
p. S146
|
article
|
| 339 |
Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11
|
Satpati, Drishty
|
|
|
122-123 |
S |
p. S47
|
article
|
| 340 |
Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer
|
Berdal, Marion
|
|
|
122-123 |
S |
p.
|
article
|
| 341 |
Development of 68Ga-labeled riboflavin analognes for RFVTs-targeted PET imaging
|
Chen, Yingxi
|
|
|
122-123 |
S |
p.
|
article
|
| 342 |
Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology
|
Hetsron, Amit
|
|
|
122-123 |
S |
p. S116
|
article
|
| 343 |
Development of 125I-labeled tetrazines
|
Bidesi, Natasha
|
|
|
122-123 |
S |
p. S52-S53
|
article
|
| 344 |
Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2
|
Laube, Markus
|
|
|
122-123 |
S |
p. S79-S80
|
article
|
| 345 |
Development of liposome-based drug-releasing radiopharmaceutical for theranosis
|
Kim, Jiyoon
|
|
|
122-123 |
S |
p.
|
article
|
| 346 |
Development of locally injectable thermo-sensitive polymer micelle using as carriers for combined radio- and chemotherapy of cancers
|
Makino, Akira
|
|
|
122-123 |
S |
p.
|
article
|
| 347 |
Development of 99mTc-labeled hexavalent c(RGDfK) peptide with optimized linker structure for in vivo imaging of integrin αvβ3
|
Mizuno, Yuki
|
|
|
122-123 |
S |
p. S7-S8
|
article
|
| 348 |
Development of new aptamer-labeled radiopharmaceuticals
|
Ozerskaya, Anastasia
|
|
|
122-123 |
S |
p. S43
|
article
|
| 349 |
Development of novel 64Cu-labelled antibodies for PET-CT imaging of TREM2
|
Shojaei, Monireh
|
|
|
122-123 |
S |
p. S104
|
article
|
| 350 |
Development of novel PSMA target therapeutic radiopharmaceuticals by modification with albumin binder
|
Lee, Kyongkyu
|
|
|
122-123 |
S |
p. S198-S199
|
article
|
| 351 |
Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals
|
Randhawa, Parmissa
|
|
|
122-123 |
S |
p. S8
|
article
|
| 352 |
Development of novel tripodal chelates for the stable chelation of theranostic radiolanthanides and actinides
|
Carbo-Bague, Imma
|
|
|
122-123 |
S |
p. S148
|
article
|
| 353 |
Development of 203Pb-labeled SSTR2 radioligands for neuroendocrine tumors (NETs) imaging
|
Chapeau, Dylan
|
|
|
122-123 |
S |
p. S54-S55
|
article
|
| 354 |
Development of peptide probes for imaging of CD206 positive macrophages in cancer
|
Zhang, Bo
|
|
|
122-123 |
S |
p. S40
|
article
|
| 355 |
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker
|
Murce, Erika
|
|
|
122-123 |
S |
p. S48-S49
|
article
|
| 356 |
Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands
|
Renk, Dana
|
|
|
122-123 |
S |
p. S100-S101
|
article
|
| 357 |
Development of radio-halogen-labeled PSMA-targeting ligand with high in vivo stability
|
Yamashita, Tomoki
|
|
|
122-123 |
S |
p.
|
article
|
| 358 |
Development of radiolabeled polymer nano- and micron-sized carriers
|
Muslimov, Albert
|
|
|
122-123 |
S |
p. S86-S87
|
article
|
| 359 |
Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake
|
He, Yingfang
|
|
|
122-123 |
S |
p. S36
|
article
|
| 360 |
Development of silicon fluoride acceptor (SiFA)-conjugated antibodies targeting TREM2 and Poly-GA repeats as new tracers for PET imaging of neurodegenerative diseases
|
Shojaei, Monireh
|
|
|
122-123 |
S |
p. S37
|
article
|
| 361 |
Development of site-specifically labelled single-domain antibody PET probe for monitoring PD-L1 expression in cancer
|
Chen, Yinfei
|
|
|
122-123 |
S |
p. S200
|
article
|
| 362 |
Development of small molecule PET-tracers targeting PD-L1
|
Bamminger, Karsten
|
|
|
122-123 |
S |
p.
|
article
|
| 363 |
Development of Solid Target Technologies for 225Ac Production with Proton Bombardment
|
Malinconico, Mario
|
|
|
122-123 |
S |
p.
|
article
|
| 364 |
Development of targeted 161Tb-radiolabeled nanoparticles
|
Lemaître, Tom
|
|
|
122-123 |
S |
p. S69
|
article
|
| 365 |
Development of Terbium-161 Based VLA-4 Targeted Theranostics
|
Iweha, Ejike
|
|
|
122-123 |
S |
p.
|
article
|
| 366 |
Development of two [99mTc]Tc(CO)3 complexes targeting the androgen receptor
|
Decuadra, Paula
|
|
|
122-123 |
S |
p. S38-S39
|
article
|
| 367 |
Development of versatile dual-modality imaging probes based on a GRPR antagonist for preoperative imaging and image-guided surgery of prostate cancer
|
Handula, Maryana
|
|
|
122-123 |
S |
p. S82
|
article
|
| 368 |
Development of 89Zr-antibody-PET imaging to evaluate improved brain targeting via transferrin receptor 1: the chelator matters
|
Wuensche, Thomas
|
|
|
122-123 |
S |
p. S24
|
article
|
| 369 |
Development of 89Zr-radiolabeled paclitaxel-loaded polymeric micelles for potential applications in personalized treatment of triple-negative breast cancer
|
Sadeghzadeh, Masoud
|
|
|
122-123 |
S |
p. S163-S164
|
article
|
| 370 |
Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for early detection of anthracycline induced cardiotoxicity in Wistar rats
|
Gill, Gurvinder
|
|
|
122-123 |
S |
p. S65-S66
|
article
|
| 371 |
Differential and staging diagnosis for NSCLC patients With [68Ga] Ga-DOTA-FAPI-04 and 2-[18F]FDG PET/CT
|
Zhou, Xin
|
|
|
122-123 |
S |
p. S46-S47
|
article
|
| 372 |
Diphosphine bifunctional chelators: [99mTc][TcO2(DP-PSMAt)2]+ tracers for PSMA imaging of prostate cancer
|
Hungnes, Ingebjorg
|
|
|
122-123 |
S |
p. S5-S6
|
article
|
| 373 |
Direct carbon-11 isotopic radiolabeling of Domperidone from [11C]CO2: application to in vivo brain PET imaging under P-glycoprotein inhibition
|
Caillé, Fabien
|
|
|
122-123 |
S |
p. S91
|
article
|
| 374 |
Direct clinical comparison of scaffold proteins [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of HER2-positive breast cancer
|
Tolmachev, Vladimir
|
|
|
122-123 |
S |
p.
|
article
|
| 375 |
Direct 11C-methylation of amines using cyclotron-produced [11C] CO2
|
Kealey, Steven
|
|
|
122-123 |
S |
p. S30
|
article
|
| 376 |
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: antagonist versus agonist
|
Cleeren, Frederik
|
|
|
122-123 |
S |
p.
|
article
|
| 377 |
Direct 18F fluorination of covalent organic framework (COF) nanosheets for PET molecular imaging
|
Kim, Dong Wook
|
|
|
122-123 |
S |
p. S161-S162
|
article
|
| 378 |
Direct 18F-labeling of a dimeric RGD peptide via F-nucleophilic substitution on a phosphonate prothesis
|
Wang, Chao
|
|
|
122-123 |
S |
p. S76
|
article
|
| 379 |
Discovery of [18F]F-687-TCO: An Optimized Tracer for Pretargeted PET Imaging in the CNS
|
Cook, Brendon
|
|
|
122-123 |
S |
p.
|
article
|
| 380 |
Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand
|
Cortes Gonzalez, Miguel Angel
|
|
|
122-123 |
S |
p.
|
article
|
| 381 |
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy
|
Piron, Bérengère
|
|
2014
|
122-123 |
S |
p. e75-e83
nvt p.
|
article
|
| 382 |
DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers
|
Tosato, Marianna
|
|
|
122-123 |
S |
p. S6-S7
|
article
|
| 383 |
DOX-PEG-198AuNPs-PEG-Tmab: multimodal radiobioconjugate for targeted radionuclide therapy of HER2-positive cancers
|
Zelechowska-Matysiak, Kinga
|
|
|
122-123 |
S |
p. S165-S166
|
article
|
| 384 |
Dual labelling platform for theranostics: PSMA-targeted imaging with 99mTc and therapy with 188Re
|
Hungnes, Ingebjorg
|
|
|
122-123 |
S |
p.
|
article
|
| 385 |
Dual PET imaging of microtubule destabilization and synaptic integrity in a mouse model of AD
|
Damuka, Naresh
|
|
|
122-123 |
S |
p.
|
article
|
| 386 |
Dual targeting of PD-L1 and integrin avb3 with a peptide tracer
|
Hu, Kuan
|
|
|
122-123 |
S |
p.
|
article
|
| 387 |
Economical radiosynthesis optimization using a multi-reaction microdroplet chip platform
|
Rios, Alejandra
|
|
|
122-123 |
S |
p. S65-S66
|
article
|
| 388 |
Editorial Board
|
|
|
|
122-123 |
S |
p. i
|
article
|
| 389 |
Editorial Board
|
|
|
|
122-123 |
S |
p. ii
|
article
|
| 390 |
Editorial Board
|
|
|
2014
|
122-123 |
S |
p. IFC-
1 p.
|
article
|
| 391 |
Editorial Board
|
|
|
|
122-123 |
S |
p. i
|
article
|
| 392 |
Editorial Board
|
|
|
|
122-123 |
S |
p.
|
article
|
| 393 |
Effect of dissolution and exposure of [18F]F– on nucleophilic 18F-fluorination
|
Mou, Zhaobiao
|
|
|
122-123 |
S |
p. S77-S78
|
article
|
| 394 |
Effect of (2-hydroxypropyl)-β-cyclodextrin on the solubility and in vivo behavior of the myocardial perfusion imaging agent [18F] FRho6G-DEG
|
Inkster, James
|
|
|
122-123 |
S |
p. S58
|
article
|
| 395 |
Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study
|
Opsomer, Tomas
|
|
|
122-123 |
S |
p. S57-S58
|
article
|
| 396 |
Effects of linker and binding motif modifications on tumor uptake and distribution of 99mTc-labeled HYNIC-based PSMA-targeting SPECT tracers
|
Lu, Kelly
|
|
|
122-123 |
S |
p.
|
article
|
| 397 |
Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptides
|
Qiao, Zheng
|
|
|
122-123 |
S |
p.
|
article
|
| 398 |
Effects of solvents on the yield of 6-bromo-7-[11C]methylpurine
|
Okamura, Toshimitsu
|
|
|
122-123 |
S |
p.
|
article
|
| 399 |
Effects of uncharged linker-modification of PSMA-617-based inhibitors on targeting properties and the pharmacokinetic profile
|
Geis, Nicolas
|
|
|
122-123 |
S |
p.
|
article
|
| 400 |
Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer
|
Kim, Heejung
|
|
|
122-123 |
S |
p. S104-S105
|
article
|
| 401 |
Efficient and cGMP-Compliant Manufacturing of C-11 PIB using Sep-Pak: A single cassette module approach for multiple productions
|
Nair, Manoj
|
|
|
122-123 |
S |
p.
|
article
|
| 402 |
Efficient and mild copper-labelling of sensitive targeting vectors with novel triazamacrocyclic chelator
|
Hierlmeier, Ina
|
|
|
122-123 |
S |
p.
|
article
|
| 403 |
Efficient cartridge-based synthesis of a novel [18F]tetrazine for large molecule labelling
|
Rokka, Johanna
|
|
|
122-123 |
S |
p. S115
|
article
|
| 404 |
Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents
|
Bobba, Kondapa
|
|
|
122-123 |
S |
p. S8-S9
|
article
|
| 405 |
Efficient 18F-fluorination for dimorpholinophosphinic fluoride
|
Wang, Tao
|
|
|
122-123 |
S |
p. S79
|
article
|
| 406 |
Efficient radiosynthesis of a new folate receptor-targeting PET tracer, [18F]fluoronicotinic acid labeled folate, for imaging lung fibrosis
|
Zhuang, Xiaoqing
|
|
|
122-123 |
S |
p.
|
article
|
| 407 |
EGSnrc Monte Carlo calculated dose distribution around brachytherapy sources
|
Tuan, Hoang
|
|
|
122-123 |
S |
p. S175-S176
|
article
|
| 408 |
Electronic cigarette aerosol deposition of [11C]nicotine in human subjects: radiosynthesis and vaping apparatus development
|
VanBrocklin, Henry
|
|
|
122-123 |
S |
p. S137-S138
|
article
|
| 409 |
Electrophilic Synthesis of 6-L-[18F]FDOPA with [18F]F2: a progress report on gas target of Cyclotron TR-Flex
|
Kniess, Torsten
|
|
|
122-123 |
S |
p.
|
article
|
| 410 |
Enabling insights into the cytochrome P450 isoform specific metabolism of radiotracers by CYP overexpressing hepatoblastoma cell lines
|
Lemm, Sandy
|
|
|
122-123 |
S |
p. S66-S67
|
article
|
| 411 |
Enantioselective Synthesis and Biological Evaluation of (R)- and (S)-[18F]OF-NB1 to Visualize GluN2B Subunit-Containing NMDA Receptors
|
Rong, Jian
|
|
|
122-123 |
S |
p.
|
article
|
| 412 |
ENBPI ligand for 68Ga: synthesis, radiolabeling optimization, and pilot myocardial perfusion imaging with ECG-gated PET
|
Muzzioli, Riccardo
|
|
|
122-123 |
S |
p. S57
|
article
|
| 413 |
Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates
|
Reissig, Falco
|
|
|
122-123 |
S |
p. S30-S31
|
article
|
| 414 |
Epigenetic modifiers in somatostatin type 2 receptor radionuclide theranostics and early transcriptional response of mouse pheochromocytoma models
|
Ullrich, Martin
|
|
|
122-123 |
S |
p. S11
|
article
|
| 415 |
Establishing the host-guest pretargeting platform with adamantane guest ligands in a xenograft model
|
Jallinoja, Vilma
|
|
|
122-123 |
S |
p. S18-S19
|
article
|
| 416 |
Establishing the role of “Design of Experiments” (DoE) in the tracer development pipeline: the synthesis and evaluation of [18F] talazoparib as a case study
|
Bowden, Gregory
|
|
|
122-123 |
S |
p. S78-S79
|
article
|
| 417 |
Evaluating the effect of an albumin binder for targeting melanoma tumors with 89Zr-Lumi804-Lys-pIBA-PEG4-LLP2A
|
Fong, Cyril
|
|
|
122-123 |
S |
p.
|
article
|
| 418 |
Evaluating the Interplay of 89Zr-labeled Radioimmunoconjugates and Fc Receptors in Genetically Engineered Mouse Models
|
Rodriguez, Cindy
|
|
|
122-123 |
S |
p.
|
article
|
| 419 |
Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy
|
Cassells, Irwin
|
|
|
122-123 |
S |
p. S50
|
article
|
| 420 |
Evaluating the potential of CCR2 for the early detection of head and neck cancer
|
Kang, Yeona
|
|
|
122-123 |
S |
p.
|
article
|
| 421 |
Evaluating the radionuclide theranostic potential of a MUC13-targeting antibody in colorectal cancer
|
Coll, Ryan
|
|
|
122-123 |
S |
p.
|
article
|
| 422 |
Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy
|
Brown, Victoria
|
|
|
122-123 |
S |
p. S101
|
article
|
| 423 |
Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis
|
Wegrzyniak, Olivia
|
|
|
122-123 |
S |
p. S44
|
article
|
| 424 |
Evaluation of a multifunctional blood-brain barrier co-culture model prepared from rat primary brain endothelial cells and astrocytes: first results
|
Schneider, Daniela
|
|
|
122-123 |
S |
p. S102-S103
|
article
|
| 425 |
Evaluation of an open-source 3D printed microfluidic system for the production of radiopharmaceuticals
|
Cotton, Jonathan
|
|
|
122-123 |
S |
p. S123-S124
|
article
|
| 426 |
Evaluation of a Radiofluorinated Probe for Imaging Cytochrome P450 46A1
|
Zhao, Chunyu
|
|
|
122-123 |
S |
p.
|
article
|
| 427 |
Evaluation of biodistribution of a novel sugar-conjugated platinum complex labeled with 191Pt in mice
|
Omokawa, Marina
|
|
|
122-123 |
S |
p.
|
article
|
| 428 |
Evaluation of 134Ce/La pair as a PET imaging surrogate for 225Ac radiotherapeutics
|
Bobba, Kondapa
|
|
|
122-123 |
S |
p.
|
article
|
| 429 |
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours
|
Narykina, Valeria
|
|
|
122-123 |
S |
p. S207-S208
|
article
|
| 430 |
Evaluation of 64Cu-labeled DOTA-polymer functionalized peptides
|
Villas Boas, Cristian Wieczorek
|
|
|
122-123 |
S |
p. S63-S64
|
article
|
| 431 |
Evaluation of [18F]FPy-T140 derivative PET imaging agents for CXCR4 in human cancer xenograft mouse models
|
Phelps, Tim
|
|
|
122-123 |
S |
p. S20
|
article
|
| 432 |
Evaluation of 18F-Labelled Radiotracers for Imaging of Sigma-2 Receptor in the Brain of Nonhuman Primates
|
Wenn, Mike
|
|
|
122-123 |
S |
p.
|
article
|
| 433 |
Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model
|
Guendel, Daniel
|
|
|
122-123 |
S |
p. S184
|
article
|
| 434 |
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation
|
Kim, Dong Hyun
|
|
|
122-123 |
S |
p.
|
article
|
| 435 |
Evaluation of Iododiflunisal on amyloid-β deposition in 5xFAD Alzheimer’s disease mouse model by Positron Emission Tomography imaging.
|
Zapero, Claudia Esposito
|
|
|
122-123 |
S |
p.
|
article
|
| 436 |
Evaluation of kit-based synthesis and delivery of 99mTc zoledronic acid as bone cancer imaging radiopharmaceutical
|
Ng, Yen
|
|
|
122-123 |
S |
p. S208
|
article
|
| 437 |
Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals
|
Phipps, Michael
|
|
|
122-123 |
S |
p. S155-S156
|
article
|
| 438 |
Evaluation of lysine modifications in the PSMA-targeting pharmacophore using positron emission tomography imaging in a preclinical model of human prostate cancer
|
Zhang, Chengcheng
|
|
|
122-123 |
S |
p.
|
article
|
| 439 |
Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy
|
Varlow, Cassis
|
|
|
122-123 |
S |
p. S109
|
article
|
| 440 |
Evaluation of 3p-C-DEPA as potential 225Ac-chelator
|
Ahenkorah, Stephen
|
|
|
122-123 |
S |
p. S49
|
article
|
| 441 |
Evaluation of PET-based Human Biodistribution of a Novel Amino Acid 11C-MeLeu PET/CT Imaging in Normal Volunteers
|
Nishii, Ryuichi
|
|
|
122-123 |
S |
p.
|
article
|
| 442 |
Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111
|
Tosato, Marianna
|
|
|
122-123 |
S |
p. S158
|
article
|
| 443 |
Evaluation of Pyridyl Benzofuran Derivative for Targeted Alpha Therapy of Alzheimer’s Disease
|
Bender, Aidan
|
|
|
122-123 |
S |
p.
|
article
|
| 444 |
Evaluation of (R)- and (S)-18F-PF-NB1 in non-human primates for imaging the GluN2B subunits of NMDA receptor complex
|
Wenn, Mike
|
|
|
122-123 |
S |
p.
|
article
|
| 445 |
Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals
|
Phipps, Michael
|
|
|
122-123 |
S |
p. S91-S92
|
article
|
| 446 |
Evaluation of selective Sc(III) complexes with a non-macrocyclic ligand for theranostics applications
|
Huclier, Sandrine
|
|
|
122-123 |
S |
p. S56
|
article
|
| 447 |
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations
|
Humpert, Swen
|
|
|
122-123 |
S |
p.
|
article
|
| 448 |
Evaluation of the binding characteristics of [18F]FBVM in non-human primates, a new radiotracer for imaging the vesicular acetylcholine transporter in vivo using positron emission tomography
|
Serriere, Sophie
|
|
|
122-123 |
S |
p. S94-S95
|
article
|
| 449 |
Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging
|
Kim, JinSil
|
|
|
122-123 |
S |
p.
|
article
|
| 450 |
Evaluation of the effect of macrocyclic ring size on Pb(II) and Cu(II) complex stability in pyridyl containing chelators
|
McNeil, Brooke
|
|
|
122-123 |
S |
p. S154
|
article
|
| 451 |
Evaluation of the effects of conjugation chemistry and different LET radionuclides in prostate cancer xenograft
|
Strand, Joanna
|
|
|
122-123 |
S |
p.
|
article
|
| 452 |
Evaluation of the therapeutic effect of taurine against Alzheimer’s disease using mGluR5 PET
|
Lee, Kyo Chul
|
|
|
122-123 |
S |
p. S93
|
article
|
| 453 |
Evaluation of the tumour targeting profile and characterisation of the metabolites for a novel stabilised minigastrin analogue
|
Hörmann, Anton
|
|
|
122-123 |
S |
p. S194-S195
|
article
|
| 454 |
Evaluation of tin dioxide as an inorganic-based stationary phase for a potential 44Ti/44Sc generator
|
Deri, Melissa
|
|
|
122-123 |
S |
p. S43
|
article
|
| 455 |
Evaluation of 44Ti/44Sc generator and 44Sc-post-processing procedures for radiopharmaceutical purposes: [44Sc]Sc-PSMA-617 and [44Sc]Sc-PSMA-I&T synthesis
|
Larenkov, Anton
|
|
|
122-123 |
S |
p. S152
|
article
|
| 456 |
Examination of bifunctional chelates for efficient labeling of affibodies with 52Mn
|
Brezovcsik, Karoly
|
|
|
122-123 |
S |
p. S147-S148
|
article
|
| 457 |
Examining the synergistic effect of radioimmunotherapy and immune checkpoint blockade for the treatment of metastatic melanoma
|
Allen, Kevin
|
|
|
122-123 |
S |
p. S33
|
article
|
| 458 |
Expanding the radiochemist’s toolbox: carbon-11 labelled formamides and isocyanides for PET tracer synthesis
|
Bonnemaire, Coralie
|
|
|
122-123 |
S |
p. S10
|
article
|
| 459 |
Experience on clinical scale formulation of ready to use [90Y] Y-hydroxyapatite microparticles utilizing 90Y produced in research reactor
|
Chakraborty, Sudipta
|
|
|
122-123 |
S |
p. S140
|
article
|
| 460 |
Exploration of 99Tc pincer-type complexes interacting with small molecules
|
Besmer, Manuel
|
|
|
122-123 |
S |
p. S6
|
article
|
| 461 |
Exploration of the fundamental chemistries of Ru and Pd for establishing 103Ru/103mRh Auger generator and 103Pd/103mRh in vivo generator
|
Thery, Marie
|
|
|
122-123 |
S |
p. S150-S151
|
article
|
| 462 |
Exploration the fluorine chemistry to develop the [18F]FS1P1 as a promise F-18 radiotracer for imaging S1PR1 in vivo
|
Qiu, Lin
|
|
|
122-123 |
S |
p. S11-S12
|
article
|
| 463 |
Exploring a Tristhione Scorpionate Ligand as a Suitable Chelator for the Theranostic Pair Antimony-119 and Antimony-117
|
Gé, Lorraine
|
|
|
122-123 |
S |
p.
|
article
|
| 464 |
Exploring bpcd ligand for theranostic radiopharmaceutical application
|
Cazzola, Emiliano
|
|
|
122-123 |
S |
p. S54
|
article
|
| 465 |
Exploring new strategies for technetium radiolabeled [1,2,4,5] tetrazines
|
Rodriguez, Gonzalo
|
|
|
122-123 |
S |
p. S60-S61
|
article
|
| 466 |
Exploring the chemical scope of light-activated protein conjugation and the photoradiosynthesis of 89Zr-antibodies
|
Earley, Daniel
|
|
|
122-123 |
S |
p. S94
|
article
|
| 467 |
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE
|
Vermeulen, Koen
|
|
|
122-123 |
S |
p. S57
|
article
|
| 468 |
Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics
|
Shalgunov, Vladimir
|
|
|
122-123 |
S |
p. S212
|
article
|
| 469 |
Extraction chromatographic separation of selenium and arsenic for accelerator target processing
|
Baumeister, Jakob
|
|
|
122-123 |
S |
p. S92-S93
|
article
|
| 470 |
Extraction of 68Ga medical radioisotopes from Zn nitrate liquid target using atomic layer deposited microfluidics
|
Santoso, Albert
|
|
|
122-123 |
S |
p.
|
article
|
| 471 |
[18F]AlF and RESCA: a novel method for radiolabeling of Affibody molecules
|
Lechi, Francesco
|
|
|
122-123 |
S |
p.
|
article
|
| 472 |
[18F]ALX5406: a brain-penetrating prodrug for GlyT1-specific PET imaging
|
Hoffmann, Chris
|
|
|
122-123 |
S |
p. S45
|
article
|
| 473 |
Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid
|
Nielsen, Karin Michaelsen
|
|
|
122-123 |
S |
p. S18-S19
|
article
|
| 474 |
18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach
|
Laube, Markus
|
|
|
122-123 |
S |
p. S61
|
article
|
| 475 |
[18F]Difluorocarbene for positron emission tomography
|
Sap, Jeroen
|
|
|
122-123 |
S |
p.
|
article
|
| 476 |
[18F]FEPPA PET imaging for monitoring the neuroinflammation status in a Lactacystin-induced Parkinson disease animal model.
|
Chiu, Ching-Hung
|
|
|
122-123 |
S |
p.
|
article
|
| 477 |
[18F]FLUDA – A promising PET probe for the non-invasive assessment of the A2A adenosine receptor
|
Lai, Thu Hang
|
|
|
122-123 |
S |
p.
|
article
|
| 478 |
18F-Fluorination Reactions and Optimizations using a Parallel Synthesis Reactor
|
Donat, Cornelius
|
|
|
122-123 |
S |
p.
|
article
|
| 479 |
[18F]Fluoroform radiolabelling of the CHK1 inhibitor CCT245737
|
Sharma, Gitanjali
|
|
|
122-123 |
S |
p. S48-S49
|
article
|
| 480 |
3-[18F]Fluoro-5-hydroxy- and 3-[18F]fluorophenylserines: Preparation and initial biological evaluation
|
Kolks, Niklas
|
|
|
122-123 |
S |
p.
|
article
|
| 481 |
5-[18F]Fluoro-m-tyrosine (5-[18F]FMT) - a novel promising tracer for dopaminergic imaging
|
Vus, Stefanie
|
|
|
122-123 |
S |
p. S38
|
article
|
| 482 |
[18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling
|
Walter, Nils
|
|
|
122-123 |
S |
p. S110
|
article
|
| 483 |
18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media
|
Kim, Min Pyeong
|
|
|
122-123 |
S |
p. S37
|
article
|
| 484 |
[18F]GP1, a novel PET tracer investigated for the detection of thrombi in LVADs and for the diagnosis of valve thrombosis
|
Hugenberg, Verena
|
|
|
122-123 |
S |
p.
|
article
|
| 485 |
[18F]hGTS13 for imaging of xC
− transporter activity in high-grade glioma
|
Kendrili, M. Tansel
|
|
|
122-123 |
S |
p.
|
article
|
| 486 |
First experiences with the SST2R-antagonist [68Ga]Ga-DATA5m-LM4 for PET imaging of tumors: preclinical comparison with [68Ga] Ga-DOTA-LM3
|
Kanellopoulos, Panagiotis
|
|
|
122-123 |
S |
p. S16-S17
|
article
|
| 487 |
First-In-Class Diagnostics Targeting Neuropeptide Y1 Receptor (Y1R): Enabling Molecular Imaging of Metastatic Breast Cancer
|
Rahimi, Marwa Nadia
|
|
|
122-123 |
S |
p.
|
article
|
| 488 |
First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer
|
Tolmachev, Vladimir
|
|
|
122-123 |
S |
p. S17-S18
|
article
|
| 489 |
First in-human studies of the glutamate transporter EAAT2 radiotracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparginate (RP-115): radiosynthesis and biodistribution evaluation
|
Nillo, Ryan Michael
|
|
|
122-123 |
S |
p.
|
article
|
| 490 |
First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor
|
Lu, Yingqing
|
|
|
122-123 |
S |
p. S15-S16
|
article
|
| 491 |
First time evaluation of 45Ti for radiolabeling of NOTA and DOTA chelators
|
Milton, Stefan
|
|
|
122-123 |
S |
p.
|
article
|
| 492 |
F-18 labeled azaindole derivatives as PET imaging tracer for tau protein
|
Kim, Dong Wook
|
|
|
122-123 |
S |
p.
|
article
|
| 493 |
18F-labeled imidazole naphthyridine derivatives as Tau imaging agents in Alzheimer’s Disease
|
Liu, Tianqing
|
|
|
122-123 |
S |
p.
|
article
|
| 494 |
18F-labeled indole-based analogs with chiral 2,3-dihydroxyfluorobutoxy side chain as highly selective sigma-2 receptor probes for tumor imaging
|
An, Xiaodan
|
|
|
122-123 |
S |
p. S196-S197
|
article
|
| 495 |
18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules
|
Hall, Andrew
|
|
|
122-123 |
S |
p. S41-S42
|
article
|
| 496 |
18F-Labelled inhibitors for targeting of IDH1 mutant gliomas
|
Neumaier, Bernd
|
|
|
122-123 |
S |
p.
|
article
|
| 497 |
18F-labelled probes for non-invasive assessment of the IDH genotype in diffuse glioma
|
Cologni, Roberta
|
|
|
122-123 |
S |
p. S17-S18
|
article
|
| 498 |
Fluoride mediated radiosynthesis of [11C]methyl esters
|
Neelamegam, Ramesh
|
|
|
122-123 |
S |
p. S73-S74
|
article
|
| 499 |
Fluorinated PET imaging probes targeting fibroblast activation protein: radiolabeling and preclinical evaluation
|
Elvas, Filipe
|
|
|
122-123 |
S |
p. S40-S41
|
article
|
| 500 |
Fluorine-18 Labeling of Neutrophil Elastase Inhibitors
|
Holm, Linus Johansson
|
|
|
122-123 |
S |
p.
|
article
|
| 501 |
Fluorine-mediated desilylative Carbon-11 carboxylation of acylsilanes with [11C]CO2 for the radiosynthesis of [1-11C]α-keto acids
|
Lee, Sanghee
|
|
|
122-123 |
S |
p.
|
article
|
| 502 |
Fluoroquinolone dithiocarbamate rhenium and technetium-99m complexes for potential infection imaging agents
|
Shegani, Antonio
|
|
|
122-123 |
S |
p. S98
|
article
|
| 503 |
18F-microbubble for PET/US imaging: conception and in vivo imaging
|
Ariztia, Julen
|
|
|
122-123 |
S |
p. S166-S167
|
article
|
| 504 |
[18F]MK-7246 for Positron Emission Tomography imaging of beta cells surface marker GRP44
|
Cheung, Pierre
|
|
|
122-123 |
S |
p.
|
article
|
| 505 |
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging
|
Lee, Kyo Chul
|
|
|
122-123 |
S |
p.
|
article
|
| 506 |
Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers
|
Corlett, Alicia
|
|
|
122-123 |
S |
p. S16-S17
|
article
|
| 507 |
Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits
|
Chakraborty, Sudipta
|
|
|
122-123 |
S |
p. S99-S100
|
article
|
| 508 |
[18F]OXD-2314: A 4R-Tau PET Radiotracer with Improved Affinity and Brain Uptake
|
Mason, Neale
|
|
|
122-123 |
S |
p.
|
article
|
| 509 |
From R&D scale to clinical trial: design of 64Cu-radiolabeled compound production for phase I process
|
Drouin, Guillaume
|
|
|
122-123 |
S |
p. S141-S142
|
article
|
| 510 |
[18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate
|
Craig, Austin
|
|
|
122-123 |
S |
p. S81
|
article
|
| 511 |
[18F]Talazoparib: a novel potential PET imaging agent of PARP
|
Muzzioli, Riccardo
|
|
|
122-123 |
S |
p. S7-S8
|
article
|
| 512 |
Fully automated and GMP-compliant synthesis of [18F]JK-PSMA-7 on a Trasis AllinOne module
|
Ermert, Johannes
|
|
|
122-123 |
S |
p. S124
|
article
|
| 513 |
Fully automated and GMP-compliant synthesis of [18F]SynVesT-1 on a Trasis AllinOne module
|
Ermert, Johannes
|
|
|
122-123 |
S |
p.
|
article
|
| 514 |
Fully automated macro- and microfluidic production and physiological animal biodistribution of [68Ga]Ga-citrate
|
Ovdiichuk, Olga
|
|
|
122-123 |
S |
p. S134-S135
|
article
|
| 515 |
Fully Automated Production of [11C]ABP688, [11C]PS13, and [11C]PIB Using a TracerMaker Synthesis Module for Clinical Studies
|
Hu, Bao
|
|
|
122-123 |
S |
p.
|
article
|
| 516 |
Fully automated purification of labelled antibody on PD-10 cartridges
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S131-S132
|
article
|
| 517 |
Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation
|
Sahu, Sudeep
|
|
|
122-123 |
S |
p. S211-S212
|
article
|
| 518 |
Fully Automated Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan ([18F]FETrp)
|
Jiang, Huailei
|
|
|
122-123 |
S |
p.
|
article
|
| 519 |
Fully automated radiosynthesis of [18F]SMBT-1 for clinical use
|
Tago, Tetsuro
|
|
|
122-123 |
S |
p.
|
article
|
| 520 |
Fully automated synthesis of [11C]nicotinamide for in vivo vitamin trafficking studies
|
Shegani, Antonio
|
|
|
122-123 |
S |
p. S74-S75
|
article
|
| 521 |
Functionality of a co-culture kidney model: testing the renal barrier with [18F]fluorodeoxyglucose
|
Sihver, Wiebke
|
|
|
122-123 |
S |
p.
|
article
|
| 522 |
Functionalization and radiolabeling of M13 bacteriophages for PET imaging
|
Trommer, Johanna
|
|
|
122-123 |
S |
p.
|
article
|
| 523 |
Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice
|
Müller, Cristina
|
|
2014
|
122-123 |
S |
p. e58-e65
nvt p.
|
article
|
| 524 |
[68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging
|
Mengel, Emilien
|
|
|
122-123 |
S |
p. S203
|
article
|
| 525 |
[68Ga]Ga-DOTA-GIP1234 for PET imaging of glucose-dependent insulinotropic polypeptide receptor (GIPR)
|
Khalil, Amina
|
|
|
122-123 |
S |
p.
|
article
|
| 526 |
[68Ga]Ga-HBED-CC-exendin-4: A new GLP1R targeting radiolabeled agent for pancreas β-cell and insulinoma imaging
|
Li, Linlin
|
|
|
122-123 |
S |
p. S47-S48
|
article
|
| 527 |
[68Ga]Ga-HBED-CC-FAPI derivatives with improved radiolabeling and specific tumor uptake
|
Li, Yuying
|
|
|
122-123 |
S |
p.
|
article
|
| 528 |
[68Ga]Ga-NODAGA-TriGalactan a new PET-tracer for imaging of the functional liver reserve
|
Zierke, Maximilian
|
|
|
122-123 |
S |
p. S65
|
article
|
| 529 |
68Ga-labeled bivalent imaging agents targeting hypoxia and PSMA in tumors
|
Liu, Tianqing
|
|
|
122-123 |
S |
p.
|
article
|
| 530 |
68Ga-labeled hypoxia and PSMA dual-targeting imaging agents
|
Liu, Tianqing
|
|
|
122-123 |
S |
p.
|
article
|
| 531 |
68Ga-labeled Siderophores as Specific Radiotracers for Bacterial Infections
|
Al-Bazaz, Silav
|
|
|
122-123 |
S |
p.
|
article
|
| 532 |
Ga-68-labelling of quinuclidine triazole-based compound
|
Kanasuwan, Apinan
|
|
|
122-123 |
S |
p. S151-S152
|
article
|
| 533 |
Gallium-68 and Copper-64 radiolabelling of hepatotropic GBVA10-9 or CPB peptide derivatives for hepatocellular carcinoma imaging
|
Brossard, Clarisse
|
|
|
122-123 |
S |
p. S153
|
article
|
| 534 |
68Ga-: 99mTc-labeled LHRH analog as new potential breast cancer imaging agents
|
Alfaya, Lucia
|
|
|
122-123 |
S |
p. S49
|
article
|
| 535 |
68Ga-radiolabeling of hepatitis E virus-like nanoparticles and evaluation of their ex vivo biodistribution in mice
|
Lambidis, Elisavet
|
|
|
122-123 |
S |
p. S106-S107
|
article
|
| 536 |
68Ga-radiolabeling reactions is a media of protic hydroxyalkylammonium ionic liquids based on diethanolammonium salts
|
Antuganov, Dmitrii
|
|
|
122-123 |
S |
p. S96-S97
|
article
|
| 537 |
68Ge/68Ga-generator: a radionuclide source or an approved drug?
|
Kvaternik, Herbert
|
|
|
122-123 |
S |
p. S100
|
article
|
| 538 |
Generation of 225Ac-DOTA-rituximab SPECT image from 64Cu-DOTA-rituximab PET image using unpaired image-to-image translation
|
Kim, Kangsan
|
|
|
122-123 |
S |
p.
|
article
|
| 539 |
Genipin enhances 131I-rituximab induced cell cytotoxicity in lymphoma cells
|
Vinod, Nagarajan
|
|
|
122-123 |
S |
p. S218
|
article
|
| 540 |
GLP-1R targeting 68Ga-exendin-4 derivatives with lower renal retention for insulinomas and β-cell mass imaging
|
Liu, Tianqing
|
|
|
122-123 |
S |
p.
|
article
|
| 541 |
Glucose-albumin nanoplatform for treating renal ischemia-reperfusion injury using reactive oxygen species scavenging properties
|
Park, Ji Yong
|
|
|
122-123 |
S |
p. S163
|
article
|
| 542 |
52gMn(II)-Labelled PSMA-ligands as bimodal PET/MR imaging probes
|
Strecker, Jonas
|
|
|
122-123 |
S |
p. S157-S158
|
article
|
| 543 |
GMP complaint production and quality control of a [99mTc]Tc-DTPA-GSA wet kit formulation
|
Denholt, Charlotte
|
|
|
122-123 |
S |
p.
|
article
|
| 544 |
GMP compliant high-yield radiosynthesis of [18F]AlF-PSMA-11 on the IBA Synthera®+ Platform
|
Kersemans, Ken
|
|
|
122-123 |
S |
p.
|
article
|
| 545 |
GMP-compliant radiosynthesis of [18F]GP1 for the detection of thrombi
|
Hugenberg, Verena
|
|
|
122-123 |
S |
p. S66
|
article
|
| 546 |
GMP-level production of radiometallated immune checkpoint inhibitor nivolumab: why and how?
|
Suchy, Mojmir
|
|
|
122-123 |
S |
p. S61-S62
|
article
|
| 547 |
GMP Production of Copper-64 for antibody and nanobody radiolabeling: liquid vs solid target
|
Hrynchak, Ivanna
|
|
|
122-123 |
S |
p.
|
article
|
| 548 |
Halogen bond in the context of At-211 radiolabeling: the case of [211At]N-succinimidyl-3-astatobenzoate
|
Yssartier, Thibault
|
|
|
122-123 |
S |
p. S159-S160
|
article
|
| 549 |
Harnessing mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition for the synthesis of site-specifically modified 89Zr-radioimmunoconjugates
|
Rodriguez, Cindy
|
|
|
122-123 |
S |
p. S21-S22
|
article
|
| 550 |
Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles
|
Tosato, Marianna
|
|
|
122-123 |
S |
p. S158-S159
|
article
|
| 551 |
Harnessing 89Zr-PET to study the pulmonary clearance of microplastics in mice
|
Keinaenen, Outi
|
|
|
122-123 |
S |
p. S55
|
article
|
| 552 |
Head-to-head comparison of [18F]Florastamin, [18F]FDG PET/CT, and 99mTc-HDP bone scintigraphy in patients with prostate cancer
|
Lee, Inki
|
|
|
122-123 |
S |
p.
|
article
|
| 553 |
Head-to-head Comparison of [18F]Florbetazine ([18F]92) and [11C] PiB in Alzheimer’s Disease
|
Li, Yuying
|
|
|
122-123 |
S |
p.
|
article
|
| 554 |
HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial
|
Tolmachev, Vladimir
|
|
|
122-123 |
S |
p.
|
article
|
| 555 |
High affinity novel CXCR4 antagonists radiolabelled with copper-67 and gallium-68 for theragnostic applications
|
Palmer, Max
|
|
|
122-123 |
S |
p. S59-S60
|
article
|
| 556 |
Highly automated solid target-based production of the emerging PET isotope cobalt-55
|
Gé, Lorraine
|
|
|
122-123 |
S |
p. S170
|
article
|
| 557 |
Highly modifiable cyclopentadienyl scaffolds for the rapid development of 99mTc radioprobes
|
Lengacher, Rapahel
|
|
|
122-123 |
S |
p. S90
|
article
|
| 558 |
High radiochemical yield and molar activity 52gMn from electroplated chromium
|
Barrett, Kendall
|
|
|
122-123 |
S |
p.
|
article
|
| 559 |
High-sensitivity ICP-MS – an alternative for in vitro and in vivo characterization of future radiometal-based theranostic candidates
|
Wallimann, Rahel
|
|
|
122-123 |
S |
p. S42-S43
|
article
|
| 560 |
High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter
|
Moein, Mohammad Mahdi
|
|
|
122-123 |
S |
p. S132-S133
|
article
|
| 561 |
High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging
|
Nelson, Bryce
|
|
|
122-123 |
S |
p. S12
|
article
|
| 562 |
[3H]OF-NB1 and [18F]OF-NB1: novel radioligands for the preclinical assessment of GluN1/2B targeting ligands
|
Ahmed, Hazem
|
|
|
122-123 |
S |
p. S95-S96
|
article
|
| 563 |
Hyaluronic acid as a potential component of radiopharmaceutical with rhenium-188 for radiosynovectomy
|
Malysheva, Anna
|
|
|
122-123 |
S |
p. S41
|
article
|
| 564 |
Hypoxia targeting lutetium-177 labeled gold nanoparticles for cancer theranostic application
|
Mittal, Sweety
|
|
|
122-123 |
S |
p. S162-S163
|
article
|
| 565 |
Identification of non-competitive lead peptides for the development of PET tracers targeting PD-L1
|
Badenhorst, Melinda
|
|
|
122-123 |
S |
p.
|
article
|
| 566 |
Identification of (R)-[18F]YH134 as a promising reversible MAGL PET tracer and the impact of peripheral MAGL blockade on its brain uptake
|
Mu, Linjing
|
|
|
122-123 |
S |
p.
|
article
|
| 567 |
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging
|
Mack, Kyeara
|
|
|
122-123 |
S |
p.
|
article
|
| 568 |
Identifying new antigens on osteosarcoma and developing novel antibodies for radioimmunotherapy
|
Prabaharan, Chandra
|
|
|
122-123 |
S |
p. S209-S210
|
article
|
| 569 |
Identifying Toxicity Mechanisms Associated with f-block Radiometals through Genome-wide Toxicogenomics
|
Pallares, Roger Molto
|
|
|
122-123 |
S |
p.
|
article
|
| 570 |
Imaging acute and chronic stress using 2-[18F]FDG PET
|
Krisch, Maximilian
|
|
|
122-123 |
S |
p.
|
article
|
| 571 |
Imaging characterization of National Cancer Institute patient derived xenograft models
|
Drake, Christopher
|
|
|
122-123 |
S |
p. S185-S186
|
article
|
| 572 |
Imaging Lung Tumor Metastasis with 89Zr-DFO-Crizanlizumab Targeting P-selectin
|
Majekodunmi, Olufolake
|
|
|
122-123 |
S |
p.
|
article
|
| 573 |
Imaging of AAV-mediated gene transfer in the brain using a novel PET reporter gene tracer
|
Stotz, Sophie
|
|
|
122-123 |
S |
p. S106-S107
|
article
|
| 574 |
Imaging the Sirtuin 2 (SIRT2) protein - [18F]PF-SIRT, a novel positron emission tomography radioligand candidate
|
Read, Cai
|
|
|
122-123 |
S |
p.
|
article
|
| 575 |
Imidazolium Salt-Mediated Radiofluorosulfurylation to Produce 18F-labeled Aryl Fluorosulfates
|
Kim, Jaegwan
|
|
|
122-123 |
S |
p.
|
article
|
| 576 |
Immune mediated inflammation and perfusion in lungs of Covid-19 patients studied with [11C]GW457427 and [15O]water: a first-in-man pilot study
|
Antoni, Gunnar
|
|
|
122-123 |
S |
p. S63
|
article
|
| 577 |
ImmunoPET imaging combined with focused ultrasound to study brain pharmacokinetic of 89Zr labeled anti-PD-L1 antibodies in a syngeneic murine model of glioblastoma
|
Chevaleyre, Céline
|
|
|
122-123 |
S |
p. S181-S182
|
article
|
| 578 |
Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research
|
Nielsen, Karin Michaelsen
|
|
|
122-123 |
S |
p.
|
article
|
| 579 |
Implementation of iMiDEV, a new fully automated microfluidic platform for radiopharmaceutical production
|
Ovdiichuk, Olga
|
|
|
122-123 |
S |
p. S60-S61
|
article
|
| 580 |
Improved droplet-based method for isotopic exchange labeling of trifluoroborate precursors
|
Lisova, Ksenia
|
|
|
122-123 |
S |
p. S64-S65
|
article
|
| 581 |
Improved Purification of Cyclotron Produced [68Ga]GaCl3 for the Radiolabeling of Dotatate
|
Wang, Ivan
|
|
|
122-123 |
S |
p.
|
article
|
| 582 |
Improved Synthesis and Automation of 2-(2,6-Difluoro-4-((2-(phenylsulfonamido)ethyl)thio)phenoxy)acetamide ([11C]K2) for Imaging AMPA Receptors
|
Witek, Jason
|
|
|
122-123 |
S |
p.
|
article
|
| 583 |
Improved Synthesis of 3-[18F]Fluoro-p-Hydroxyphenethylguanidine ([18F]3F-PHPG) for Clinical Evaluation of Paraganglioma, Pheochromocytoma and Related Neuroendocrine Tumors
|
Brooks, Allen
|
|
|
122-123 |
S |
p.
|
article
|
| 584 |
Improved synthesis of [18F]FPATPP via Ru-mediated 18F-Fluorination
|
Rajala, Noora
|
|
|
122-123 |
S |
p. S135
|
article
|
| 585 |
Improvements in separation of antimony-119 from bulk tin target using a novel dibutyl ether resin
|
Grundmane, Aivija
|
|
|
122-123 |
S |
p.
|
article
|
| 586 |
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-74
|
Toms, Johannes
|
|
|
122-123 |
S |
p.
|
article
|
| 587 |
Improving the quality of Ga radionuclides to achieve high radiolabeling yields
|
Grundler, Pascal
|
|
|
122-123 |
S |
p. S45
|
article
|
| 588 |
111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies
|
Chung, Sebastian
|
|
|
122-123 |
S |
p. S50
|
article
|
| 589 |
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India
|
Chakraborty, Sudipta
|
|
|
122-123 |
S |
p. S180-S181
|
article
|
| 590 |
Influence of albumin binders on tumor uptake of [225Ac]Ac-mcp-PSMA radioconjugates
|
Mamat, Constantin
|
|
|
122-123 |
S |
p. S29
|
article
|
| 591 |
Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody
|
Rauscher, A.
|
|
2014
|
122-123 |
S |
p. e66-e74
nvt p.
|
article
|
| 592 |
Influence of radiolysis on astatine-211 chemistry
|
Ghalei, Mohammad
|
|
|
122-123 |
S |
p. S142
|
article
|
| 593 |
Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer
|
Bobba, Kondapa
|
|
|
122-123 |
S |
p. S53
|
article
|
| 594 |
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis
|
Vizier, Romane
|
|
|
122-123 |
S |
p. S120
|
article
|
| 595 |
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis
|
Vizier, Romane
|
|
|
122-123 |
S |
p. S97
|
article
|
| 596 |
Initial in vitro study of superparamagnetic iron oxide nanoparticles coated with 198AU for targeted radionuclide therapy and magnetic hyperthermia
|
Zuk, Michal
|
|
|
122-123 |
S |
p. S87
|
article
|
| 597 |
Initial results of clinical phase 0 study on [68Ga]Ga-BOT5035/PET for the assessment of fibrosis activity
|
Velikyan, Irina
|
|
|
122-123 |
S |
p. S68-S69
|
article
|
| 598 |
111In-labeled-anti-EphA2 antibody for SPECT imaging tracer targeting erythropoietin-producing hepatocellular receptor A2
|
Kimura, Hiroyuki
|
|
|
122-123 |
S |
p.
|
article
|
| 599 |
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results
|
Arkins, Chase
|
|
|
122-123 |
S |
p.
|
article
|
| 600 |
In search of the HIV reservoir and a cure: translation of a CD30 imaging agent
|
VanBrocklin, Henry
|
|
|
122-123 |
S |
p. S52
|
article
|
| 601 |
Intermediates en route to [99mTc]Tc-sestamibi: insights from HPLC and HPLC-MS
|
do Mar Machado, Joana
|
|
|
122-123 |
S |
p. S36
|
article
|
| 602 |
INTERNATIONAL SCIENTIFIC PROGRAM COMMITTEE
|
|
|
|
122-123 |
S |
p.
|
article
|
| 603 |
Intramolecular Friedel-Crafts acylation of carbon-11 isocyanates enabling radiolabeling of [carbonyl-11C]DPQ
|
Pichler, Verena
|
|
|
122-123 |
S |
p.
|
article
|
| 604 |
INTRODUCTION
|
Cutler, Cathy S.
|
|
|
122-123 |
S |
p. S1-S2
|
article
|
| 605 |
Introduction of a polyethylene glycol linker enhances uptake of 64Cu-NOTA-conjugated lactam-cyclized alpha-MSH peptide in melanoma
|
Qiao, Zheng
|
|
|
122-123 |
S |
p. S70
|
article
|
| 606 |
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM3
|
Favaretto, Chiara
|
|
|
122-123 |
S |
p.
|
article
|
| 607 |
Introduction to this Abstract Supplement
|
|
|
|
122-123 |
S |
p. iii
|
article
|
| 608 |
Introduction to this Abstract Supplement
|
|
|
|
122-123 |
S |
p. ii
|
article
|
| 609 |
Investigating different chelators for a pretargeting approach with 203:212Pb- and 64:67Cu-labeled tetrazines
|
Bauer, David
|
|
|
122-123 |
S |
p. S28-S29
|
article
|
| 610 |
Investigating the chemical scope of protein-ligation using photoactivatable chelates
|
Earley, Daniel
|
|
|
122-123 |
S |
p. S114
|
article
|
| 611 |
Investigating the stereochemical requirements in the design of 68Ga-radiolabelled fibroblast activation protein inhibitors
|
Flores, Jose Esteban
|
|
|
122-123 |
S |
p. S187
|
article
|
| 612 |
Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer
|
Mack, Kyeara
|
|
|
122-123 |
S |
p. S58-S59
|
article
|
| 613 |
Investigation into metabolic profile of [11C]Me-DPA
|
Thomas, Keller
|
|
|
122-123 |
S |
p.
|
article
|
| 614 |
Investigation of cell surface murine CD68 as a pan-macrophage biomarker by immunoSPECT and optical imaging
|
Roohani, Borna
|
|
|
122-123 |
S |
p.
|
article
|
| 615 |
Investigation of [18F]Regioisomer Formation in the Radiofluorination of Hypervalent Aryl Iodonium Salts and Ylides
|
Zhao, Qunchao
|
|
|
122-123 |
S |
p.
|
article
|
| 616 |
Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications
|
Imlimthan, Surachet
|
|
|
122-123 |
S |
p. S56-S57
|
article
|
| 617 |
Investigation of therapeutic effect, associated hypoxia and antioxidant signaling induced by copper-64 in colon carcinoma
|
Niculae, Dana
|
|
|
122-123 |
S |
p.
|
article
|
| 618 |
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands
|
Müller, Cristina
|
|
|
122-123 |
S |
p. S27-S28
|
article
|
| 619 |
In vitro and in vivo evaluation of a 89Zr-labeled anti-TIP1 antibody
|
Villas Boas, Cristian Wieczorek
|
|
|
122-123 |
S |
p. S37-S38
|
article
|
| 620 |
In vitro and in vivo evaluation of [11C]M4K2127 for PET imaging activin receptor-like kinase 2
|
Chasse, Melissa
|
|
|
122-123 |
S |
p.
|
article
|
| 621 |
In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast cancer
|
Schmitt, Sébastien
|
|
|
122-123 |
S |
p. S205
|
article
|
| 622 |
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK6240
|
Bansal, Aditya
|
|
|
122-123 |
S |
p. S99-S100
|
article
|
| 623 |
In vitro binding characteristic evaluation of radioconjugates targeting NRP-1 and: or NK1 receptor on glioma cancer model
|
Halik, Pawel
|
|
|
122-123 |
S |
p. S53-S54
|
article
|
| 624 |
In vitro Characterizations of an S1PR1 Specific Radioligand [3H] CS1P1 in the Central Nervous System
|
Jiang, Hao
|
|
|
122-123 |
S |
p. S30
|
article
|
| 625 |
In vitro evaluation of [18F]FDG-N3 cell uptake and intracellular SPAAC reactivity using Hoechst-DBCO
|
Kovacs, Luciana
|
|
|
122-123 |
S |
p.
|
article
|
| 626 |
In vitro evaluation of 18F-fluorinated D-methionine and D-tyrosine derivatives as potential radiotracers for PET imaging of bacterial infection
|
Betts, Helen
|
|
|
122-123 |
S |
p. S63-S64
|
article
|
| 627 |
In vitro evaluation of GPR17 radioligands as potential CNS stem cell imaging agents
|
Kealey, Steven
|
|
|
122-123 |
S |
p. S38-S39
|
article
|
| 628 |
In Vitro Evaluation of [3H]PI-2620 and Structural Derivative in non-Alzheimer’s Tauopathies
|
Varlow, Cassis
|
|
|
122-123 |
S |
p.
|
article
|
| 629 |
In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor
|
Tawate, Megha
|
|
|
122-123 |
S |
p. S213
|
article
|
| 630 |
In vivo assessment of TNF-a expression by SPECT/CT antibod imaging using click chemistry in mice models of rheumatoid arthritis
|
Yoo, Min Young
|
|
|
122-123 |
S |
p.
|
article
|
| 631 |
In vivo evaluation and optimization of [89Zr]Zr-DFO-NCS and [89Zr] Zr-(oxinate)4 for cell tracking
|
Friberger, Ida
|
|
|
122-123 |
S |
p.
|
article
|
| 632 |
In vivo evaluation of carbon-11 labeled CRANAD-102 as a potential PET tracer for soluble species of amyloid-β species in the brain
|
Staudt, Markus
|
|
|
122-123 |
S |
p. S105
|
article
|
| 633 |
In vivo evaluation of carbon-11 labeled 6,7-dimethoxy-1,2,3,4-tetrahydroinsoquinoline derivatives (11C-4-MPTHQ) for potential use as σ2R brain PET tracer
|
Kim, Ho Young
|
|
|
122-123 |
S |
p. S40
|
article
|
| 634 |
In vivo evaluation of [18F]Fluoroethyl Fucose: a PET tracer for imaging and studying tumor senescence
|
Cotton, Jonathan
|
|
|
122-123 |
S |
p.
|
article
|
| 635 |
In vivo PET imaging of 89Zr-labelled Natural Killer cell trafficking to solid tumour under the influence of a therapeutic antibody
|
Pham, Truc
|
|
|
122-123 |
S |
p.
|
article
|
| 636 |
4-Iodophenyl-[18F]fluorosulfate as a versatile building block for Pd-catalyzed cross-coupling reactions
|
Humpert, Swen
|
|
|
122-123 |
S |
p.
|
article
|
| 637 |
Isoindoline bridged [M(arene)2]+ ansa-[3]arenophanes of rhenium and 99mtechnetium
|
Csucker, Joshua
|
|
|
122-123 |
S |
p. S4
|
article
|
| 638 |
Isolation of glioblastoma cancer stem cells by sedimentation field flow fractionation for the development of 3D models in supramolecular hydrogels
|
Battu, Serge
|
|
|
122-123 |
S |
p. S160
|
article
|
| 639 |
Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging
|
Caillé, Fabien
|
|
|
122-123 |
S |
p. S64
|
article
|
| 640 |
131I-urease nanomotors as potential radiotherapeutic agents for bladder cancer
|
Gómez, María
|
|
|
122-123 |
S |
p.
|
article
|
| 641 |
133/135La-labeling of bleomycin and its initial radiopharmacological evaluation
|
Nelson, Bryce
|
|
|
122-123 |
S |
p. S59
|
article
|
| 642 |
Lanatoside C enhances [225Ac]Ac-DOTA-rituximab induced cell cytotoxicity in lymphoma cells
|
Nagarajan, Vinod
|
|
|
122-123 |
S |
p. S31
|
article
|
| 643 |
Lanatoside C enhances 131I-rituximab treatment in Raji lymphoma cells
|
Song, Kanghyon
|
|
|
122-123 |
S |
p.
|
article
|
| 644 |
Large scale reliable production of [carboxyl-11C]acetate on the Synthra synthesizer.
|
Solovyev, Dmitry
|
|
|
122-123 |
S |
p.
|
article
|
| 645 |
LC/MS coupled to radioactive detection for the chemical characterization of radiopharmaceuticals: identification of multiple intermediates en route to [99mTc]Tc-sestamibi
|
do Mar Ferreira Machado, Joana
|
|
|
122-123 |
S |
p.
|
article
|
| 646 |
Leveraging an open science approach for PET radiotracer discovery: radiolabelling and preliminary neuroimaging of 11C-labelled activin receptor-like kinase 2 inhibitors
|
Murrell, Emily
|
|
|
122-123 |
S |
p. S41
|
article
|
| 647 |
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.
|
Moreno, Oscar
|
|
|
122-123 |
S |
p.
|
article
|
| 648 |
Long term experience in [11C]UCB-J production in Turku PET Centre
|
Krzyczmonik, Anna
|
|
|
122-123 |
S |
p. S126-S127
|
article
|
| 649 |
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors
|
Rodman, Samuel
|
|
|
122-123 |
S |
p.
|
article
|
| 650 |
177Lu-, 225Ac- and 111In-labelled nonadentate bispidine ligands: synthesis, radiolabelling experiments and stability assays
|
Kopp, Ina
|
|
|
122-123 |
S |
p. S11
|
article
|
| 651 |
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry
|
Sanders, Vanessa
|
|
|
122-123 |
S |
p. S25-S26
|
article
|
| 652 |
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours
|
Kubeil, Manja
|
|
|
122-123 |
S |
p. S68
|
article
|
| 653 |
177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands
|
Kuo, Hsiou-Ting
|
|
|
122-123 |
S |
p. S32-S33
|
article
|
| 654 |
177Lu-labeling of on-resin clicked and cyclized HER2-targeting A9 peptide
|
Sharma, Amit
|
|
|
122-123 |
S |
p. S47
|
article
|
| 655 |
[177Lu]Lu-DOTA-A9: A peptide probe targeting HER2 receptors
|
Sharma, Amit
|
|
|
122-123 |
S |
p. S47
|
article
|
| 656 |
[177Lu]Lu-labeled gold nanoparticles as tumor hypoxia targeting platforms
|
Mittal, Sweety
|
|
|
122-123 |
S |
p. S85-S86
|
article
|
| 657 |
[177Lu]Lu-labeled NaGdF4:Ho-Yb@m-SiO2 upconversion nanophosphors: synthesis and characterization as a potent theranostic probe
|
Chakraborty, Sudipta
|
|
|
122-123 |
S |
p. S58-S59
|
article
|
| 658 |
[177Lu]Lu3+ labeling of Erlotinib analogues targeting EGFR-expressing cancers
|
Jain, Akanksha
|
|
|
122-123 |
S |
p. S196
|
article
|
| 659 |
Making samrium-153 available for targeted radionuclide therapy
|
Van de Voorde, Michiel
|
|
|
122-123 |
S |
p. S13
|
article
|
| 660 |
Management of legacy radioactive waste from [153Sm]Sm-lexidronam radiopharmaceutical
|
Cusnir, Ruslan
|
|
|
122-123 |
S |
p. S65
|
article
|
| 661 |
Mannose Receptor (CD206) Targeting with Aluminum Fluoride-18 Labeled Mannosylated Dextran
|
Andriana, Putri
|
|
|
122-123 |
S |
p.
|
article
|
| 662 |
Manual labeling, bio-distribution and administration of 177Lu-DOTATE: our long term insight at NORI
|
Bokhari, Ayesha
|
|
|
122-123 |
S |
p. S122
|
article
|
| 663 |
Mass production of 64, 67Cu using accelerator-based fast neutrons
|
Kawabata, Masako
|
|
|
122-123 |
S |
p.
|
article
|
| 664 |
Measurements of 186Re production cross section induced by deuterons on natW target at ARRONAX facility
|
Guertin, Arnaud
|
|
2014
|
122-123 |
S |
p. e16-e18
nvt p.
|
article
|
| 665 |
Metabolic stability and tumor uptake improvements via an ABD-arm in [99mTc]Tc-DT10: first preclinical experiences in pancreatic cancer models
|
Maina-Nock, Theodosia
|
|
|
122-123 |
S |
p. S17
|
article
|
| 666 |
Metabolites identification of the selective αvβ3 RGDechi chimeric peptides and their [99mTc][Tc(N)PNP]-derivatives
|
Carpanese, Debora
|
|
|
122-123 |
S |
p. S44
|
article
|
| 667 |
Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery
|
Graham, Thomas
|
|
|
122-123 |
S |
p. S13
|
article
|
| 668 |
Method development for centralized clinical production of 177Lu-PNT2002
|
Dornan, Mark
|
|
|
122-123 |
S |
p.
|
article
|
| 669 |
mGluR5 exploration in healthy subject by [18F]FPEB
|
Vercouillie, Johnny
|
|
|
122-123 |
S |
p. S109
|
article
|
| 670 |
Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors
|
Zhang, Wei
|
|
|
122-123 |
S |
p. S88-S89
|
article
|
| 671 |
Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155
|
Cassells, Irwin
|
|
|
122-123 |
S |
p. S53-S54
|
article
|
| 672 |
Mitochondria-targeted radiocomplexes for cancer theranostics
|
Fernandes, Célia
|
|
|
122-123 |
S |
p. S51-S52
|
article
|
| 673 |
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG
|
Schulte, Michael
|
|
|
122-123 |
S |
p. S135-S136
|
article
|
| 674 |
Modification of the synthesis of 18F-labeled FC-119S for our automated synthesizer
|
Kato, Koichi
|
|
|
122-123 |
S |
p.
|
article
|
| 675 |
Molecular imaging and radiopharmaceutical therapy of Multiple Myeloma targeting CD46 using 89Zr and 225Ac-YS5
|
Wadhwa, Anju
|
|
|
122-123 |
S |
p.
|
article
|
| 676 |
Molecular imaging for systemic treatment decisions in patients with cancer
|
de Vries, Elisabeth GE
|
|
|
122-123 |
S |
p. S1
|
article
|
| 677 |
Molecular imaging of alcoholic liver disease with phosphodiesterase (PDE) 4B targeted [18F]PF-06445974 and positron emission tomography
|
Shao, Tuo
|
|
|
122-123 |
S |
p. S18
|
article
|
| 678 |
Molecular imaging of cerebral dysfunction following liver failure with cannabinoid receptor type I targeted [18F]MK-9470 and positron emission tomography
|
Shao, Tuo
|
|
|
122-123 |
S |
p. S53-S54
|
article
|
| 679 |
Molecular imaging of LPS induced neuroinflammation with P2x7 targeted [18F]JNJ-64413739 by positron emission tomography
|
Chen, Jiahui
|
|
|
122-123 |
S |
p. S92-S93
|
article
|
| 680 |
Molecular imaging of murine liver fibrosis with sphingosine-1-phosphate receptor 1 targeted PET ligand
|
Shao, Tuo
|
|
|
122-123 |
S |
p. S55-S56
|
article
|
| 681 |
Molecular imaging of Poly (ADP-ribose) polymerase for nnalcoholic steatohepatitis detection in preclinical models
|
Jeppesen, Troels
|
|
|
122-123 |
S |
p. S67-S68
|
article
|
| 682 |
Molecular imaging of PSA using DARPin scaffolds
|
Gut, Melanie
|
|
|
122-123 |
S |
p. S190-S191
|
article
|
| 683 |
Molecular Radiation Resistance Signature Induced by Alpha Emitters in Metastatic Castration-resistant Prostate Cancer: Early Clinical Outcome Prediction
|
Amghar, Mariam
|
|
|
122-123 |
S |
p.
|
article
|
| 684 |
99mTc-labeled PSMA SPECT CT: a cost effective alternate of PET CT in diagnostic algorithm of prostate cancer
|
Mir, Kahkashan
|
|
|
122-123 |
S |
p. S204
|
article
|
| 685 |
99mTc/Re tricarbonyl biguanide complexes for cancer theranostics
|
Xiong, Chiyi
|
|
|
122-123 |
S |
p. S58
|
article
|
| 686 |
[99mTc]Tc-HYNIC-EcgDf21: a defensin short analog with potential application in infection foci imaging
|
Gretter, Mariella Terán
|
|
|
122-123 |
S |
p. S63
|
article
|
| 687 |
[99mTc]Tc-(η6-pharm)2]+ synthesis with direct labelling of pharmaceuticals in water
|
Battistin, Federica
|
|
|
122-123 |
S |
p. S3
|
article
|
| 688 |
[99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer
|
Wojdowska, Wioletta
|
|
|
122-123 |
S |
p.
|
article
|
| 689 |
Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers
|
Żelechowska-Matysiak, Kinga
|
|
|
122-123 |
S |
p. S86
|
article
|
| 690 |
Nanoparticles as a Radionuclide Generator System for 225Ac/213Bi
|
Diehl, George
|
|
|
122-123 |
S |
p.
|
article
|
| 691 |
Nanoscale microfluidic reactions: towards near-stoichiometric carbon-11 radiolabelling for PET
|
Edgar, Fraser
|
|
|
122-123 |
S |
p. S69-S70
|
article
|
| 692 |
Nanosized crystalline vehicle for targeted radionuclide therapy
|
Lemaître, Tom
|
|
|
122-123 |
S |
p.
|
article
|
| 693 |
Neuroimaging of p38 MAPK with [11C]SCIO-469 Enabled by Inhibition of P-glycoprotein
|
Chasse, Melissa
|
|
|
122-123 |
S |
p.
|
article
|
| 694 |
New bicyclic somatostatin receptor agonists for imaging and therapy of neuroendocrine neoplasia
|
Franchi, Sara
|
|
|
122-123 |
S |
p. S66-S67
|
article
|
| 695 |
New bifunctional linchpin for tandem peptide cyclization/ radiometal incorporation
|
Yuen, Richard
|
|
|
122-123 |
S |
p. S120
|
article
|
| 696 |
New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy
|
Vivier, Delphine
|
|
|
122-123 |
S |
p. S218-S219
|
article
|
| 697 |
New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides
|
Svedjehed, Johan
|
|
|
122-123 |
S |
p. S72
|
article
|
| 698 |
New H2dedpa derivatives designed for [67/68Ga]Ga3+ and [64Cu]Cu2+ radiopharmaceutical applications
|
de Guadalupe Jaraquemada-Pelaez, Maria
|
|
|
122-123 |
S |
p. S149
|
article
|
| 699 |
NEw materials for conducting radiosynthesis of 18F-compounds
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S129-S130
|
article
|
| 700 |
New phase transfer agents for fluorine 18 radiolabelling
|
Pelletier, Rémi
|
|
|
122-123 |
S |
p. S16-S17
|
article
|
| 701 |
New prospects for 89Zr-immuno-PET in brain applications: Alpha-synucleinopathies
|
Wuensche, Thomas
|
|
|
122-123 |
S |
p.
|
article
|
| 702 |
New way to refine direct aromatic 18F-labeling of tetrazines
|
Andersen, Ida
|
|
|
122-123 |
S |
p. S76
|
article
|
| 703 |
Next generation copper complexes for efficient production of radiolabeled aromatics
|
Hoffmann, Chris
|
|
|
122-123 |
S |
p.
|
article
|
| 704 |
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives
|
Castilla, Susana Granados
|
|
|
122-123 |
S |
p.
|
article
|
| 705 |
Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers
|
Corlett, Alicia
|
|
|
122-123 |
S |
p. S16
|
article
|
| 706 |
Non-invasive assessment of fibrogenesis by PET imaging using a [Al18F]RESCA-Affibody molecule targeting PDGFRβ
|
Wegrzyniak, Olivia
|
|
|
122-123 |
S |
p.
|
article
|
| 707 |
Non-invasive imaging of neutrophils in acute sepsis
|
Wilske, Frida
|
|
|
122-123 |
S |
p.
|
article
|
| 708 |
Noninvasive imaging of STING expression in tumor microenvironment using radioiodinated small molecule
|
Fang, Jianyang
|
|
|
122-123 |
S |
p. S52
|
article
|
| 709 |
Novel bifunctional [16]aneS4-derived chelators for soft radiometals
|
Straathof, Natan
|
|
|
122-123 |
S |
p. S157
|
article
|
| 710 |
Novel boron-containing amino acid analogs for tumor positron tomography and boron neutron capture therapy
|
Chen, Junyi
|
|
|
122-123 |
S |
p. S181
|
article
|
| 711 |
Novel FAPI tracers with albumin-binding properties for cancer imaging and therapy
|
Meng, Lingxin
|
|
|
122-123 |
S |
p. S59
|
article
|
| 712 |
Novel folate radioconjugates: optimization of functional units to improve the tissue distribution profile
|
Becker, Anna
|
|
|
122-123 |
S |
p. S11-S12
|
article
|
| 713 |
Novel 68Ga-labelled nanobody for imaging of platelet-derived growth factor receptor beta
|
Velikyan, Irina
|
|
|
122-123 |
S |
p.
|
article
|
| 714 |
Novel [68Ga/177Lu]Ga/Lu-AAZTA-PSMA-093 as PSMA targeting agent for diagnosis and radiotherapy
|
Liu, Tianqing
|
|
|
122-123 |
S |
p.
|
article
|
| 715 |
Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer
|
Artschwager, Raik
|
|
|
122-123 |
S |
p. S177
|
article
|
| 716 |
Novel 99mTc labelled proline isocyanide derivatives as potential tumour imaging agents
|
Ruan, Qing
|
|
|
122-123 |
S |
p. S43-S44
|
article
|
| 717 |
Novel pyrazolethiazole derivatives as a promising new class of ligands for alpha-synuclein fibrils and potential PET tracers for the detection of α-synucleinopathies
|
Bonanno, Federica
|
|
|
122-123 |
S |
p.
|
article
|
| 718 |
Novel pyrazolethiazole derivatives as new high affinity and selective ligands for alpha-synuclein fibrils as potential PET tracers for Parkinson’s disease
|
Bonanno, Federica
|
|
|
122-123 |
S |
p. S90-S91
|
article
|
| 719 |
Novel Radiofluorination via Electrophilic Activation of Alkyl Phosphates/Phosphonate
|
Zhang, Kaiqiang
|
|
|
122-123 |
S |
p.
|
article
|
| 720 |
Novel Universal Agent for Cutaneous Radioactive Decontamination
|
Craig, Austin
|
|
|
122-123 |
S |
p.
|
article
|
| 721 |
Occupancy of Glucagon Like Peptide-1 receptor by Tirzepatide and SAR441255 measured with [68Ga]Ga-DO3A-exendin-4/PET in vivo.
|
Khalil, Amina
|
|
|
122-123 |
S |
p.
|
article
|
| 722 |
O-[18F]fluoroalkylation of phenol derivatives with [18F] epifluorohydrin in the presence of t-Bu-P4 base
|
Fujinaga, Masayuki
|
|
|
122-123 |
S |
p.
|
article
|
| 723 |
One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module
|
Zheng, Qi-Huang
|
|
|
122-123 |
S |
p. S139-S140
|
article
|
| 724 |
‘One-fits-both’: searching a ligand for the chelation of theranostic mercury and silver radioisotopes
|
Tosato, Marianna
|
|
|
122-123 |
S |
p. S11-S12
|
article
|
| 725 |
One-step automated radiosynthesis of N-succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB)
|
Nagachinta, Surasa
|
|
|
122-123 |
S |
p. S117
|
article
|
| 726 |
On the regiochemistry of the synthesis of 18F-labelled difluoroarenes via the copper mediated substitution of tin derivatives
|
Stouse, Adrien
|
|
|
122-123 |
S |
p. S36-S37
|
article
|
| 727 |
Open-shell nanosensitizers for glutathione-responsive sonodynamic therapy of breast cancer
|
Ni, Dalong
|
|
|
122-123 |
S |
p. S26-S27
|
article
|
| 728 |
Operation of a thorium-229/actinium-225 generator at Canadian Nuclear Laboratories
|
Perron, Randy
|
|
|
122-123 |
S |
p.
|
article
|
| 729 |
Optical Imaging with a biological vector for diagnosis of oncologic diseases
|
Thakur, Mathew
|
|
|
122-123 |
S |
p.
|
article
|
| 730 |
Optimal ‘hardness’ of non-macrocyclic chelators for [203Pb]Pb2+ radiopharmaceutical applications
|
Ingham, Aidan
|
|
|
122-123 |
S |
p. S25
|
article
|
| 731 |
Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S128-S129
|
article
|
| 732 |
Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator
|
Huclier-Markai, S.
|
|
2014
|
122-123 |
S |
p. e36-e43
nvt p.
|
article
|
| 733 |
Optimization of reaction volumes and reagent amounts for the preparation of various 18F-radiolabelled radiotracers
|
Maindron, Nicolas
|
|
|
122-123 |
S |
p. S130
|
article
|
| 734 |
Optimization of the automated radiosynthesis of an 18F-labeled tetrahydroquinoline derivative for brain HDAC6 imaging
|
Tago, Tetsuro
|
|
|
122-123 |
S |
p.
|
article
|
| 735 |
Optimization of the routine production of the ketone body tracer (R)-[11C]3-hydroxybutyric acid
|
Nielsen, Erik
|
|
|
122-123 |
S |
p. S23-S24
|
article
|
| 736 |
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer
|
Jussing, Emma
|
|
|
122-123 |
S |
p.
|
article
|
| 737 |
Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer
|
Le Roux, Alexandre
|
|
|
122-123 |
S |
p. S3-S4
|
article
|
| 738 |
Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging
|
Bratteby, Klas
|
|
|
122-123 |
S |
p. S79-S80
|
article
|
| 739 |
Optimized quality control analysis for GMP production of the clinical 18F-labelled NET tracer [18F]SiTATE
|
Kerminen, Edla
|
|
|
122-123 |
S |
p.
|
article
|
| 740 |
Optimized Radiosynthesis of Racemic 2-[18F]Fluoropropionic Acid for PET Imaging of Incipient Heart Failure
|
Singh, Pradeep
|
|
|
122-123 |
S |
p.
|
article
|
| 741 |
Optimized synthesis of tri(hydroxypyridinone)-tetrazine and 68Ga-radiolabeling for bioorthogonal chemistry
|
Centanni, Alessia
|
|
|
122-123 |
S |
p. S50-S51
|
article
|
| 742 |
Optimized synthesis of tris(hydroxypyridinone)-tetrazine and 68Ga radiolabeling for bioorthogonal chemistry
|
Centanni, Alessia
|
|
|
122-123 |
S |
p. S148-S149
|
article
|
| 743 |
Optimizing 203Pb cyclotron production and availability: The ideal SPECT imaging theranostic partner for 212Pb targeted alpha therapy
|
Nelson, Bryce
|
|
|
122-123 |
S |
p.
|
article
|
| 744 |
Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein
|
Bratteby, Klas
|
|
|
122-123 |
S |
p. S87-S88
|
article
|
| 745 |
Organometallic cancer theranostics: incorporation of Re and 99mTc into the small molecule kinase inhibitor Opaganib®
|
Lengacher, Raphael
|
|
|
122-123 |
S |
p. S55-S56
|
article
|
| 746 |
Organotin derivatives as versatile precursors for the radioiodination and radiofluorination of 1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (TIC(OH)) analogues
|
Maisonial-Besset, Aurélie
|
|
|
122-123 |
S |
p. S17
|
article
|
| 747 |
Original 18F-thiol prosthetic group for labeling of dehydroalanine-containing biologics
|
Richard, Mylène
|
|
|
122-123 |
S |
p. S75
|
article
|
| 748 |
Our experiences working with the development module Neptis x Seed
|
Ohlsson, Tomas
|
|
|
122-123 |
S |
p.
|
article
|
| 749 |
[15O]Water – a timeless challenge under GMP
|
Ross, Tobias
|
|
|
122-123 |
S |
p.
|
article
|
| 750 |
Palladium-mediated synthesis of 11C-labelled acyl amidines and their cyclization to 11C-labelled 1,2,4-oxadiazoles from aryl halides and amidines
|
Roslin, Sara
|
|
|
122-123 |
S |
p.
|
article
|
| 751 |
PAM and FUS-assisted local AAV gene delivery into the brain of Alzheimer’s disease murine models assessed by quantitative PET reporter gene
|
Ajenjo, Javier
|
|
|
122-123 |
S |
p.
|
article
|
| 752 |
3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals
|
Ahenkorah, Stephen
|
|
|
122-123 |
S |
p. S10-S11
|
article
|
| 753 |
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models
|
Kim, Kyungwon
|
|
|
122-123 |
S |
p. S15
|
article
|
| 754 |
PEGylation modulation of peptides promotes PET detection of cancers
|
Hu, Kuan
|
|
|
122-123 |
S |
p. S88-S89
|
article
|
| 755 |
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl
|
Oza, Dhvani
|
|
|
122-123 |
S |
p. S5
|
article
|
| 756 |
Perfluoroaryl azide staudinger reaction combined with sulfur [18F]Fluoride exchange click chemistry for live cell radiolabeling
|
Biti, Anisa
|
|
|
122-123 |
S |
p. S78
|
article
|
| 757 |
Performance assessment of quantitative preclinical SPECT imaging with 155Tb and 161Tb
|
Koniar, Helena
|
|
|
122-123 |
S |
p.
|
article
|
| 758 |
Performance evaluation of the IRIS XL-220 PET/CT system, a new camera dedicated to non-human primates
|
Boisson, Frédéric
|
|
|
122-123 |
S |
p. S173
|
article
|
| 759 |
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis
|
Villas Boas, Cristian Wieczorek
|
|
|
122-123 |
S |
p.
|
article
|
| 760 |
PET/CT Imaging Reveals Enhanced Spleen Uptake After Humanization of an Annexin A1 Targeting Antibody
|
Houson, Hailey
|
|
|
122-123 |
S |
p.
|
article
|
| 761 |
PET imaging and biological uptake of toxic diesel particulate matter in mice via different routes of exposure
|
Park, Jung Eun
|
|
|
122-123 |
S |
p.
|
article
|
| 762 |
PET Imaging of [68Ga]Ga-NOTA-insulin in Alzheimer’s disease mouse model
|
Pandey, Mukesh
|
|
|
122-123 |
S |
p.
|
article
|
| 763 |
PET imaging of lung inflammation in pig by neutrophil elastase inhibitor [11C]GW457427
|
Eriksson, Olof
|
|
|
122-123 |
S |
p. S65
|
article
|
| 764 |
PET imaging of neurotensin receptor-positive tumors with 68Ga-labeled antagonists: “the chelate makes again the difference”
|
Renard, Emma
|
|
|
122-123 |
S |
p. S6-S7
|
article
|
| 765 |
PET Imaging of Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
|
Houson, Hailey
|
|
|
122-123 |
S |
p.
|
article
|
| 766 |
PET imaging of PD-L1 expression in brain tumours
|
Sharma, Gitanjali
|
|
|
122-123 |
S |
p.
|
article
|
| 767 |
PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide
|
Hu, Kuan
|
|
|
122-123 |
S |
p. S2
|
article
|
| 768 |
Pharmacokinetic, dosimetry and antitumor efficacy of 64Cu/NOTA-terpyridine platinum, a potential radio-chemo-theranostic agent
|
Khosravifarsani, Meysam
|
|
|
122-123 |
S |
p. S57
|
article
|
| 769 |
Pharmacokinetic preclinical evaluation of radioligation strategies impact on antibody fragment targeting PD-L1
|
Truillet, Charles
|
|
|
122-123 |
S |
p. S118-S119
|
article
|
| 770 |
Pharmacokinetics, Dosimetry and Therapeutic efficacy of [225Ac] Ac-DOTA-TDA-Lipiodol® in a murine cancer model: The importance of considering the actinium-225 in vivo generated decay daughters for accurate treatment dosing
|
Josefsson, Anders
|
|
|
122-123 |
S |
p.
|
article
|
| 771 |
Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit
|
Orlova, Anna
|
|
|
122-123 |
S |
p.
|
article
|
| 772 |
Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates
|
Delaney, Samantha
|
|
|
122-123 |
S |
p. S17-S18
|
article
|
| 773 |
PhotoDynamicTherapy by Cerenkov luminescence induct by Gallium-68 on AGuIX@Terbium-porphyrin ultrasmall nanoparticle
|
Collet, Charlotte
|
|
|
122-123 |
S |
p. S161
|
article
|
| 774 |
Photoredox-assisted 18F-radiodeoxyfluorination of diaryl ethers favors the more electron-rich aryl group
|
Jiang, Meijuan
|
|
|
122-123 |
S |
p.
|
article
|
| 775 |
Polyacrylamide gel electrophoresis based method for investigation of metabolic stability of [68Ga]Ga-BOT5035 in vitro and in vivo
|
Velikyan, Irina
|
|
|
122-123 |
S |
p.
|
article
|
| 776 |
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience
|
Fonseca, Alexandra
|
|
|
122-123 |
S |
p. S44-S45
|
article
|
| 777 |
Preclinical assessment of nanoparticles conjugated with 64Cu-DOTA-PEG-BBN targeting gastrin-releasing peptide receptors
|
Niculae, Dana
|
|
|
122-123 |
S |
p. S14-S15
|
article
|
| 778 |
Preclinical characterization of [18F]FB-labeled single-domain antibodies for PET imaging of FAP-α or Folate-α overexpression in cancer
|
Dierick, Herlinde
|
|
|
122-123 |
S |
p.
|
article
|
| 779 |
Preclinical development of CD133 targeted immunoPET probes
|
Wyszatko, Kevin
|
|
|
122-123 |
S |
p. S19-S20
|
article
|
| 780 |
Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
|
Alvarez, Natalia Herrero
|
|
|
122-123 |
S |
p. S192-S193
|
article
|
| 781 |
Preclinical evaluation of antisense-oligonucleotide (ASO) brain distribution using PET and SPECT imaging post intrathecal injection
|
Rafidi, Hanine
|
|
|
122-123 |
S |
p.
|
article
|
| 782 |
Preclinical evaluation of ePSMA-DM1: a PSMA-targeting theranostic small molecule drug conjugate
|
Seimbille, Yann
|
|
|
122-123 |
S |
p.
|
article
|
| 783 |
Preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter
|
Vercouillie, Johnny
|
|
|
122-123 |
S |
p. S110
|
article
|
| 784 |
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation
|
Holzleitner, Nadine
|
|
|
122-123 |
S |
p.
|
article
|
| 785 |
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide
|
El Fakiri, Mohamed
|
|
|
122-123 |
S |
p.
|
article
|
| 786 |
Preclinical evaluation of GRPR-antagonists based on a highly stable variant for imaging of prostate cancer
|
Kanellopoulos, Panagiotis
|
|
|
122-123 |
S |
p.
|
article
|
| 787 |
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer
|
Kanellopoulos, Panagiotis
|
|
|
122-123 |
S |
p.
|
article
|
| 788 |
Pre-clinical evaluation of lead-203 as an imaging surrogate for lead-212 radiopharmaceuticals
|
Cagle, Brianna
|
|
|
122-123 |
S |
p. S22-S23
|
article
|
| 789 |
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors
|
Wharton, Luke
|
|
|
122-123 |
S |
p.
|
article
|
| 790 |
Preclinical evaluation of [89Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC)
|
Bratteby, Klas
|
|
|
122-123 |
S |
p.
|
article
|
| 791 |
Preclinical evaluation of [89Zr]Zr-ramucirumab: the monoclonal antibody for imaging of VEGFR2 positive tumors
|
Novy, Zbynek
|
|
|
122-123 |
S |
p. S56-S57
|
article
|
| 792 |
Preclinical PET imaging of GSK-3 in pancreatic cancer
|
Boyle, Amanda
|
|
|
122-123 |
S |
p. S19
|
article
|
| 793 |
Preclinical validation of [18F]-FB-(Anti Human PD-L1) nanobody for PET imaging
|
Dierick, Herlinde
|
|
|
122-123 |
S |
p. S141
|
article
|
| 794 |
Preface of the Workshop on Innovative Personalized Radioimmunotherapy (WIPR 2013)
|
Huclier, Sandrine
|
|
2014
|
122-123 |
S |
p. e1-e6
nvt p.
|
article
|
| 795 |
Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging
|
Guttormsen, Yngve
|
|
|
122-123 |
S |
p. S42-S43
|
article
|
| 796 |
Preliminary evaluation of 124I labeled virus receptor binding domain
|
Li, Dan
|
|
|
122-123 |
S |
p. S50-S51
|
article
|
| 797 |
Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer
|
Jussing, Emma
|
|
|
122-123 |
S |
p. S197-S198
|
article
|
| 798 |
Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases
|
Thompson, Stephen
|
|
|
122-123 |
S |
p. S107-S108
|
article
|
| 799 |
Preparation and evaluation of an ADAM8-targeted 111In-labeled antibody for the detection of early pancreatic cancer
|
Fuchigami, Takeshi
|
|
|
122-123 |
S |
p.
|
article
|
| 800 |
Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model
|
Wen, Li
|
|
|
122-123 |
S |
p. S164-S165
|
article
|
| 801 |
Preparation and preclinical evaluation of novel 18F-labeled FAP ligands
|
Hoffmann, Chris
|
|
|
122-123 |
S |
p.
|
article
|
| 802 |
Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction
|
Craig, Austin
|
|
|
122-123 |
S |
p. S80
|
article
|
| 803 |
Preparation of a representative non-radioactive sterility sample during the preparation of a long-lived radiopharmaceutical
|
Stuijt, Jeffrey
|
|
|
122-123 |
S |
p.
|
article
|
| 804 |
Preparation of 211At-labeled aromatic compounds from thioarylprecursors
|
Maingueneau, Clémence
|
|
|
122-123 |
S |
p. S43-S44
|
article
|
| 805 |
Preparation of electrodeposited UO2 target for fission-99Mo production
|
Shen, Yijia
|
|
|
122-123 |
S |
p. S103-S104
|
article
|
| 806 |
Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans
|
Kolks, Niklas
|
|
|
122-123 |
S |
p. S35
|
article
|
| 807 |
Preparation of Infective Endocarditis Models and PET Imaging Studies Using [18F]FDG and Other Radiotracers
|
Lim, Jeong Eun
|
|
|
122-123 |
S |
p.
|
article
|
| 808 |
Preparation of radiofluorinated tyrosine derivatives via 18F-SuFEx chemistry and their in vivo evaluation
|
Walter, Nils
|
|
|
122-123 |
S |
p. S76
|
article
|
| 809 |
Preparation of radiolabeled sulfamoyl fluorides by SuFEx 18F/19F isotopic exchange and assessment of their in vivo stability
|
Hoffmann, Chris
|
|
|
122-123 |
S |
p.
|
article
|
| 810 |
Preparation of titanium complexes for in vivo PET imaging
|
Strecker, Jonas
|
|
|
122-123 |
S |
p. S8-S9
|
article
|
| 811 |
Preparing a 18F-labeled modification of a PD-L1 inhibitor via [18F] SuFEx reaction
|
Craig, Austin
|
|
|
122-123 |
S |
p. S80-S81
|
article
|
| 812 |
Preparing Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist [18F]Ubrogepant to Enable Biodistribution Studies in Non-Human Primate
|
Fan, Kuo-Hsien
|
|
|
122-123 |
S |
p.
|
article
|
| 813 |
Pressed chromium/sodium fluoride target for cyclotron production of manganese-52
|
Nielsen, Karin Michaelsen
|
|
|
122-123 |
S |
p. S102-S103
|
article
|
| 814 |
Pretargeted Alpha Therapy of Disseminated Cancer - Combining Click Chemistry and Astatine-211
|
Timperanza, Chiara
|
|
|
122-123 |
S |
p.
|
article
|
| 815 |
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids
|
Auchynnikava, Tatsiana
|
|
|
122-123 |
S |
p.
|
article
|
| 816 |
Process validation of Ga-68 labelled FAPI-46 at HUS Diagnostic Center
|
Koivula, Teija
|
|
|
122-123 |
S |
p. S143-S144
|
article
|
| 817 |
Production and application of the 203Pb/212Pb theranostic pair at TRIUMF
|
McNeil, Brooke
|
|
|
122-123 |
S |
p. S95-S96
|
article
|
| 818 |
Production and characterization of high purity radioscandium isotopes, 43,47Sc, of clinical interest from proton bombardment on enriched [46,50Ti]TiO2 targets
|
Cingoranelli, Shelbie
|
|
|
122-123 |
S |
p. S49-S50
|
article
|
| 819 |
Production and purification of the Auger emitters Lanthanum-135 and Erbium-165
|
Pedersen, Kristina
|
|
|
122-123 |
S |
p.
|
article
|
| 820 |
Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging
|
Favaretto, Chiara
|
|
|
122-123 |
S |
p. S50-S51
|
article
|
| 821 |
Production of clinical amounts GMP compliant zirconium-89 from cyclotron liquid targets: towards global availability of 89Zr-based radiopharmaceuticals
|
Silva, Magda
|
|
|
122-123 |
S |
p.
|
article
|
| 822 |
Production of emerging theranostic radionuclides at TRIUMF
|
Radchenko, Valery
|
|
|
122-123 |
S |
p. S172
|
article
|
| 823 |
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections
|
Jouad, Kamal
|
|
|
122-123 |
S |
p.
|
article
|
| 824 |
Production of high-specific-activity erbium-169, ytterbium-175 and thulium-167
|
Talip, Zeynep
|
|
|
122-123 |
S |
p. S13-S14
|
article
|
| 825 |
Production of 117mSn using Sb alloy targetry
|
Baumeister, Jakob
|
|
|
122-123 |
S |
p. S23-S24
|
article
|
| 826 |
Production of PET Radiopharmaceutical for Cholinergic Imaging
|
Latter, Melissa
|
|
|
122-123 |
S |
p.
|
article
|
| 827 |
Production of Strontium-85 via deuteron-induced nuclear reactions on natural rubidium
|
Tanzey, Sean
|
|
|
122-123 |
S |
p. S22
|
article
|
| 828 |
Production of 89Zr from cyclotron using yttrium foil: a new target design
|
Pandey, Mukesh
|
|
|
122-123 |
S |
p. S103
|
article
|
| 829 |
Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor
|
Lu, Jie
|
|
|
122-123 |
S |
p. S199
|
article
|
| 830 |
Proof-of-concept optimization of copper-mediated radiosynthesis of [18F]FBnTP using a novel automated robotic high-throughput droplet radiochemistry system
|
Jones, Jason
|
|
|
122-123 |
S |
p.
|
article
|
| 831 |
Proof of principle: [18F]AlF radiolabelling using a droplet microreactor
|
Lu, Yingqing
|
|
|
122-123 |
S |
p.
|
article
|
| 832 |
Protein 18F radiolabelling by Snap-Tag: synthesis and radiofluorination of O6-benzylguanine derivatives
|
Ariztia, Julen
|
|
|
122-123 |
S |
p. S77
|
article
|
| 833 |
Quality assessment of cyclotron-produced 67Cu
|
Brühlmann, Santiago
|
|
|
122-123 |
S |
p. S42
|
article
|
| 834 |
Quality control of 99mTc-radiopharmaceuticals: assessing our clinical practice
|
do Mar Ferreira Machado, Joana
|
|
|
122-123 |
S |
p.
|
article
|
| 835 |
Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture
|
Pichler, Verena
|
|
|
122-123 |
S |
p. S14
|
article
|
| 836 |
Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS
|
Lahdenpohja, Salla
|
|
|
122-123 |
S |
p. S174
|
article
|
| 837 |
Quantitative Evaluation of a Novel PET Radioligand for the Monoacylglycerol Lipase (MAGL) in Non-Human Primates
|
Gu, Jiwei
|
|
|
122-123 |
S |
p.
|
article
|
| 838 |
Quick determination of 90SR/90Y for application in nuclear medicine by counting gross-beta activity
|
Tuan, Hoang
|
|
|
122-123 |
S |
p. S172
|
article
|
| 839 |
Radiation-induced DNA Damage and Repair in Targeted Radionuclide Therapies in Comparison to External Beam Radiation
|
Winter, Ruth
|
|
|
122-123 |
S |
p.
|
article
|
| 840 |
Radioactive Isotopes for Cancer Radiotherapy
|
Hoehr, Cornelia
|
|
|
122-123 |
S |
p. S2
|
article
|
| 841 |
Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers
|
Wawrowicz, Kamil
|
|
|
122-123 |
S |
p. S48
|
article
|
| 842 |
Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations
|
Larenkov, Anton
|
|
|
122-123 |
S |
p. S152
|
article
|
| 843 |
Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3
|
Tawate, Megha
|
|
|
122-123 |
S |
p. S146
|
article
|
| 844 |
Radiochemical synthesis and automation of an 18F-radiolabelled oligonucleotide for PET imaging of miRNA-223 in relation to neuroinflammation
|
Zientek, Simon
|
|
|
122-123 |
S |
p. S113-S114
|
article
|
| 845 |
Radiochemical synthesis of [18F]Fluoroanilines via flow reduction
|
Wilde, Justin
|
|
|
122-123 |
S |
p. S139
|
article
|
| 846 |
Radiofluorination of Ruppert-Prakash reagent (Me3SiC[18F]F3) for syntheses of 18F-trifluoromethylated compounds
|
Pees, Anna
|
|
|
122-123 |
S |
p. S23
|
article
|
| 847 |
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism
|
Wright, Jay
|
|
|
122-123 |
S |
p.
|
article
|
| 848 |
Radioiodinated and astatinated NHC rhodium complexes: Synthesis
|
Rajerison, Holisoa
|
|
2014
|
122-123 |
S |
p. e23-e29
nvt p.
|
article
|
| 849 |
Radioiodination of galacto-bombesin using a residualizing prosthetic agent for imaging of gastrin-releasing peptide receptor
|
Lim, Hwisoo
|
|
|
122-123 |
S |
p.
|
article
|
| 850 |
Radioiodination of prosthetic groups for disulphide rebridging
|
Krzyczmonik, Anna
|
|
|
122-123 |
S |
p.
|
article
|
| 851 |
Radioisotope-loaded microbubbles for cancer imaging and therapy
|
Gower-Fry, Kaley
|
|
|
122-123 |
S |
p. S149-S150
|
article
|
| 852 |
Radiolabeled chimeric interlukine-1 (IL-1) receptor antagonist for imaging tumor microenvironment of colorectal cancer
|
Liu, Zhonglin
|
|
|
122-123 |
S |
p. S202
|
article
|
| 853 |
Radiolabeled gold nanoseeds containing substance P peptides: synthesis, characterization and evaluation in glioblastoma cells
|
Raposinho, Paula
|
|
|
122-123 |
S |
p. S30
|
article
|
| 854 |
Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine
|
Gower-Fry, Kaley
|
|
|
122-123 |
S |
p.
|
article
|
| 855 |
Radiolabeled peptidomimetic inhibitors of the VEGF:NRP-1 complex as diagnostic: therapeutic radiopharmaceuticals
|
Masłowska, Katarzyna
|
|
|
122-123 |
S |
p. S56
|
article
|
| 856 |
Radiolabeled supramolecular coordination complexes targeted to somatostatin receptors
|
Deiser, Sandra
|
|
|
122-123 |
S |
p. S73-S74
|
article
|
| 857 |
Radiolabeling and biological evaluation of functionalized spherical nucleic acids
|
Auchynnikava, Tatsiana
|
|
|
122-123 |
S |
p. S39-S40
|
article
|
| 858 |
Radiolabeling and evaluation of cyclohexyl (5-(2-acetamidobenzo[d]thiazol-6-yl)-2-methylpyridin-3-yl) carbamate (PK68), a potent inhibitor for receptor interacting protein 1 kinase (RIPK1)
|
Kumata, Katsushi
|
|
|
122-123 |
S |
p. S113
|
article
|
| 859 |
Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor
|
Zhang, Qian
|
|
|
122-123 |
S |
p. S222
|
article
|
| 860 |
Radiolabeling and in vitro studies of scandium-44 with HOPO chelator for PET imaging
|
Gajecki, Leah
|
|
|
122-123 |
S |
p. S52-S53
|
article
|
| 861 |
Radiolabeling and preclinical evaluation of a novel PET ligand for imaging phosphodiesterase (PDE) 4B
|
Chen, Jiahui
|
|
|
122-123 |
S |
p. S91-S92
|
article
|
| 862 |
Radiolabeling of HER2 targeting single domain antibody with Tc-99m and Re-188
|
Altunay, Betül
|
|
|
122-123 |
S |
p. S6
|
article
|
| 863 |
Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice
|
Frindel, Mathieu
|
|
2014
|
122-123 |
S |
p. e49-e57
nvt p.
|
article
|
| 864 |
Radiolabeling of hyaluronan and hyaluronan-α
vβ6-Binding Peptide for PET imaging
|
Zhang, Hua
|
|
|
122-123 |
S |
p.
|
article
|
| 865 |
Radiolabeling of small molecules and peptides with therapeutic radionuclide Cu-67 for theranostic applications
|
Pike, Susan
|
|
|
122-123 |
S |
p. S156
|
article
|
| 866 |
Radiolabeling of two different precursors of m-[211At] astatobenzylguanidine using 211At purified by wet extraction.
|
Kang, Choong Mo
|
|
|
122-123 |
S |
p.
|
article
|
| 867 |
Radiolabelling of biomolecules with an original exo-maleimide prosthetic group
|
Richard, Mylène
|
|
|
122-123 |
S |
p. S117-S118
|
article
|
| 868 |
Radiolabelling of DOTA-Kisspeptin with gallium-68 and lutetium-177
|
Kleynhans, Janke
|
|
|
122-123 |
S |
p. S143
|
article
|
| 869 |
Radiolabelling of small extracellular vesicles with gallium-68
|
Kunnas, Jonne
|
|
|
122-123 |
S |
p.
|
article
|
| 870 |
Radiometabolite structural confirmation of [11C]CS1P1, a promising radiotracer for imaging neuroinflammation of patients with Multiple Sclerosis
|
Qiu, Lin
|
|
|
122-123 |
S |
p.
|
article
|
| 871 |
Radionuclide therapy with the second-generation Affibody molecule [188Re]Re-Z41071 improves survival in mice bearing human HER2-expressing xenografts
|
Liu, Yongsheng
|
|
|
122-123 |
S |
p. S27
|
article
|
| 872 |
Radiopharmaceutical preparation and quality control of 225Ac-DOTAGA-IAC for tumor targeted alpha therapy (TAT)
|
Pandey, Somit
|
|
|
122-123 |
S |
p. S144-S145
|
article
|
| 873 |
Radiopharmaceutical production and stability studies of 18F-rhPSMA-7.3 injection on a Siemens Explora GN Synthesis Module
|
Haka, Michael
|
|
|
122-123 |
S |
p.
|
article
|
| 874 |
Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells
|
Sihver, Wiebke
|
|
|
122-123 |
S |
p.
|
article
|
| 875 |
Radiosynthesis and analysis of (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid
|
Brown, Gavin
|
|
|
122-123 |
S |
p.
|
article
|
| 876 |
Radiosynthesis and biological evaluation of a nicotinic acid hydroxamate derivative as a radioligand for HDAC6 PET imaging
|
Tago, Tetsuro
|
|
|
122-123 |
S |
p. S107
|
article
|
| 877 |
Radiosynthesis and biological evaluation of 10-[11C] methoxy-berberine as a novel PET tracer for visualizing berberine metabolism and distribution in mice
|
Zhang, Xiaojun
|
|
|
122-123 |
S |
p. S69
|
article
|
| 878 |
Radiosynthesis and biological evaluation of [18F]AG-120 as imaging agent for the detection of the mutant isocitrate dehydrogenase 1 in glioma by PET
|
Toussaint, Magali
|
|
|
122-123 |
S |
p.
|
article
|
| 879 |
Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography
|
Dillemuth, Pyry
|
|
|
122-123 |
S |
p. S18-S19
|
article
|
| 880 |
Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET imaging
|
Willmann, Michael
|
|
|
122-123 |
S |
p. S35-S36
|
article
|
| 881 |
Radiosynthesis and biological investigation of an 18F-labeled triazolopyridopyrazine-based inhibitor for imaging of the phosphodiesterase 2A enzyme (PDE2A) in brain
|
Wenzel, Barbara
|
|
|
122-123 |
S |
p. S111
|
article
|
| 882 |
Radiosynthesis and Characterisation of [18F]antagomir-223: A Potential PET Radiotracer for Imaging Neuroinflammation
|
Zientek, Simon
|
|
|
122-123 |
S |
p.
|
article
|
| 883 |
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 2
|
Mori, Wakana
|
|
|
122-123 |
S |
p.
|
article
|
| 884 |
Radiosynthesis and Evaluation of a Novel 18F-Labeled Tracer for PET Imaging of Glycogen Synthase Kinase-3 (GSK-3)
|
Li, Yinlong
|
|
|
122-123 |
S |
p.
|
article
|
| 885 |
Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition
|
Harada, Ryuichi
|
|
|
122-123 |
S |
p.
|
article
|
| 886 |
Radiosynthesis and first preclinical evaluation of an 18F-radiolabelled ligand for cancer stem cells non-invasive PET imaging
|
Toussaint, Magali
|
|
|
122-123 |
S |
p. S216
|
article
|
| 887 |
Radiosynthesis and in vitro comparison of [225Ac]Ac-DOTA-dhPzPEG4- and [225Ac]Ac-macropa-tzPEG3Sq-conjugated ch806, a tumour-specific anti-EGFR antibody, and preclinical evaluation in a murine glioma model
|
Wichmann, Christian
|
|
|
122-123 |
S |
p. S14-S15
|
article
|
| 888 |
Radiosynthesis and in vitro evaluation of [99mTc]-labeled hyaluronic acid derivatives
|
Sarasamkan, Jiradanai
|
|
|
122-123 |
S |
p. S156-S157
|
article
|
| 889 |
Radiosynthesis and preclinical biodistribution of a carbon-11-labelled STING agonist
|
Hill, James
|
|
|
122-123 |
S |
p. S193
|
article
|
| 890 |
Radiosynthesis and preclinical evaluation of [11C]mitragynine isotopomers in rodents
|
Seo, Jinpyo
|
|
|
122-123 |
S |
p.
|
article
|
| 891 |
Radiosynthesis and Preliminary Evaluation of a 18F-Labeled PET Tracer Targeting CYP1B1
|
Li, Yuying
|
|
|
122-123 |
S |
p.
|
article
|
| 892 |
Radiosynthesis and preliminary evaluation of an 18F-labeled diarylpyrrole-based PET tracer targeting COX-2
|
Li, Yuying
|
|
|
122-123 |
S |
p.
|
article
|
| 893 |
Radiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imagingRadiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imaging
|
Suzuki, Chie
|
|
|
122-123 |
S |
p.
|
article
|
| 894 |
Radiosynthesis, in vitro and in vivo evaluation of [18F]Z-3540 for imaging 4R-tauopathies
|
Lindberg, Anton
|
|
|
122-123 |
S |
p.
|
article
|
| 895 |
Radiosynthesis, in vitro and in vivo evaluations of [3H]/[18F]CBD-2115 as first in class radiotracers for imaging 4R-tauopathies
|
Lindberg, Anton
|
|
|
122-123 |
S |
p. S9-S10
|
article
|
| 896 |
Radiosynthesis of [11C]EHT1610, a potential radioligand for quantification of cerebral DYRK1A by PET imaging
|
POUTREL, Pauline
|
|
|
122-123 |
S |
p. S95
|
article
|
| 897 |
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein
|
Yu, Qingzhen
|
|
|
122-123 |
S |
p. S97-S98
|
article
|
| 898 |
Radiosynthesis of D-[1-11C]alanine and D-[3-11C]alanine isotopomers
|
Rabbitt, Sarah
|
|
|
122-123 |
S |
p.
|
article
|
| 899 |
Radiosynthesis of [18F]AmBF3-Tyr3-Octreotides with Tetrazine Ligation Based on the Inverse Electron-Demand Diels–Alder Reaction: Rapid, Catalyst-free and Mild Conversion of 1,4-Dihydropyridazines to Pyridazines
|
Otaru, Sofia
|
|
|
122-123 |
S |
p.
|
article
|
| 900 |
Radiosynthesis of [18F]2- and [18F]4-fluoro[1,3]-pyrimidines
|
Kumar, Dileep
|
|
|
122-123 |
S |
p. S82-S83
|
article
|
| 901 |
Radiosynthesis of [18F]fluoroadenosine derivative : a new imaging agent for HSP70
|
Ghosh, Pradip
|
|
|
122-123 |
S |
p. S72-S73
|
article
|
| 902 |
Radiosynthesis of [18F]FP-CIT using azetidinium salt precursor and evaluation of radiochemical purity and stability
|
Kim, Dong Hyun
|
|
|
122-123 |
S |
p. S126
|
article
|
| 903 |
Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging
|
Sorlin, Alexandre
|
|
|
122-123 |
S |
p. S68
|
article
|
| 904 |
Radiosynthesis of [18F]talazoparib and biodistribution study in PC3 prostate tumor mice
|
Zhou, Dong
|
|
|
122-123 |
S |
p. S45
|
article
|
| 905 |
Radiosynthesis of [18F]VU6010572 as a PET radiotracer for imaging metabotropic glutamate receptor 3 (mGluR3)
|
Rong, Jian
|
|
|
122-123 |
S |
p. S100-S101
|
article
|
| 906 |
Radiosynthesis of new PET tracer targeting macrophage mannose receptor
|
Andriana, Putri
|
|
|
122-123 |
S |
p. S62-S63
|
article
|
| 907 |
Radiosynthesis of novel PET tracers for α-synuclein imaging
|
Hoang, Anh
|
|
|
122-123 |
S |
p. S96
|
article
|
| 908 |
Rapid and Efficient Syntheses of [11C]Trifluoroethoxy Heteroarenes with a Novel 11C-Labeling Synthon, [11C]CF3CH2OK
|
Zhao, Qunchao
|
|
|
122-123 |
S |
p.
|
article
|
| 909 |
Rapid and precise quantification of radiochemical yields by analytical HPLC with post column injection
|
Humpert, Swen
|
|
|
122-123 |
S |
p.
|
article
|
| 910 |
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform
|
Lu, Yingqing
|
|
|
122-123 |
S |
p.
|
article
|
| 911 |
223Ra-radiolabeling: predicting stability using molecular modelling
|
Mohaman, Hamissou
|
|
|
122-123 |
S |
p. S154-S155
|
article
|
| 912 |
64 reactions in an hour using an automated, robotic high-throughput radiochemistry optimization platform
|
Jones, Jason
|
|
|
122-123 |
S |
p. S59
|
article
|
| 913 |
Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure
|
Keinänen, Outi
|
|
|
122-123 |
S |
p.
|
article
|
| 914 |
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery
|
Dunling, Eleanor
|
|
|
122-123 |
S |
p. S43-S44
|
article
|
| 915 |
Reducing protodeboronation using a novel boronic ester in the late-stage copper-mediated radiofluorination
|
Jaworski, Carolin
|
|
|
122-123 |
S |
p. S46-S47
|
article
|
| 916 |
Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers
|
Valpreda, Giulia
|
|
|
122-123 |
S |
p. S34-S35
|
article
|
| 917 |
Reduction of pertechnetate by chemical and photochemical approaches and incorporation of Tc(IV) into titanium dioxide for wasteform development
|
Salcedo, Ramsey
|
|
|
122-123 |
S |
p. S7
|
article
|
| 918 |
Reductive N-11C-methylation of anilines in dimethyl sulfoxide using in situ generated [11C]formaldehyde and 2-methylpyridine-borane
|
Zhang, Ming-Rong
|
|
|
122-123 |
S |
p.
|
article
|
| 919 |
Re/99mTc complexes of 1,8-naphthalimide with varying linkers as dual-modality imaging agents
|
Prabhu, Priyanka Jagadeesa
|
|
|
122-123 |
S |
p. S41-S42
|
article
|
| 920 |
Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis
|
Holloway, Travis
|
|
|
122-123 |
S |
p. S63
|
article
|
| 921 |
Reports on the advancements of organotrifluoroborates and their use in PET imaging
|
Lozada, Jerome
|
|
|
122-123 |
S |
p.
|
article
|
| 922 |
Rhenium and technetium complexes in extremely low oxidation states
|
Salsi, Federico
|
|
|
122-123 |
S |
p. S3-S4
|
article
|
| 923 |
Same-day solid target productions of clinically relevant quantities of 89Zr, 61Cu, and 68Ga by a single operator using a single chemistry module
|
Svedjehed, Johan
|
|
|
122-123 |
S |
p.
|
article
|
| 924 |
Scale-up and optimisation of 199Au production from natPt0 and successful 199Au-labelling of bis-pyridine
|
Rosecker, Veronika
|
|
|
122-123 |
S |
p.
|
article
|
| 925 |
Scale up production and purification of high specific activity lead-203 (203Pb)
|
Saini, Shefali
|
|
|
122-123 |
S |
p.
|
article
|
| 926 |
Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands – potential radionuclide theranostics for treatment of glioblastoma multi-forme
|
Wyatt, Naomi
|
|
|
122-123 |
S |
p. S93-S94
|
article
|
| 927 |
Scandium exopolysaccharide complexes: evaluation of antiproliferative properties of on several cancer cell lines
|
Munoz-Garcia, Javier
|
|
|
122-123 |
S |
p. S195-S196
|
article
|
| 928 |
Scandium(III) and macrocyclic cavity of DOTA-like ligands: implications for design of chelators for scandium radioisotopes
|
Urbanovsky, Peter
|
|
|
122-123 |
S |
p. S68
|
article
|
| 929 |
(S)-2-(3-(carboxymethyl)ureido)-3-((2-hydroxy-3,4-dioxocyclobut-1-en-1-yl)amino)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging
|
Liu, Tianqing
|
|
|
122-123 |
S |
p.
|
article
|
| 930 |
SCIFI: exciting BODIPY compounds with 89Zr-generated Cerenkov radiation
|
Gristwood, Katie
|
|
|
122-123 |
S |
p. S167
|
article
|
| 931 |
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography
|
Lin, Wilson
|
|
|
122-123 |
S |
p.
|
article
|
| 932 |
Short PEG linkers considerably reduce background noise in immuno-PET tumor imaging
|
Nam, Bora
|
|
|
122-123 |
S |
p. S207
|
article
|
| 933 |
Silicon-based Fluoride Acceptor (SiFA) on solid supports: a new versatile tool for 18F-fluorination of peptides and biological structures
|
Steffann, Marine
|
|
|
122-123 |
S |
p. S87
|
article
|
| 934 |
Simple and quick indirect radioiodination to antibody without HPLC purification using fluorous solid-phase extraction and click reaction
|
Im, Changkeun
|
|
|
122-123 |
S |
p. S125-S126
|
article
|
| 935 |
Simple and rapid automated synthesis of L-[11C]glutamine
|
Fujinaga, Masayuki
|
|
|
122-123 |
S |
p. S124-S125
|
article
|
| 936 |
Simple method for the production of [11C]phosgene
|
Krzyczmonik, Anna
|
|
|
122-123 |
S |
p. S72-S73
|
article
|
| 937 |
Site-selective 18F-labelling of octreotide via disulfide rebridging
|
Richard, Mylène
|
|
|
122-123 |
S |
p. S86
|
article
|
| 938 |
Site-selective labelling of biomolecules via disulfide rebridging
|
Richard, Mylène
|
|
|
122-123 |
S |
p. S4
|
article
|
| 939 |
Site-specifically THP-functionalized hPD-L1 single-domain antibody: preliminary data toward kit development
|
Dierick, Herlinde
|
|
|
122-123 |
S |
p.
|
article
|
| 940 |
Site-specific [68Ga]Ga radiolabelling of antibodies through methionine conjugation
|
Chi Yue, Thomas Tin
|
|
|
122-123 |
S |
p.
|
article
|
| 941 |
Site-specific radiofluorination of peptides via chemoselective S-arylation with 4-[18F]Fluoroiodobenzene
|
Francis, Felix
|
|
|
122-123 |
S |
p. S116
|
article
|
| 942 |
Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic
|
Feng, Yutian
|
|
|
122-123 |
S |
p. S32
|
article
|
| 943 |
Site-specific 89Zr-labeling of a VHH construct as a half-life extending building block for PET and TRNT applications
|
Leekens, Simon
|
|
|
122-123 |
S |
p.
|
article
|
| 944 |
Small-molecule antagonist radiotracers for positron emission tomography imaging of the mu opioid receptor.
|
Plakas, Konstantinos
|
|
|
122-123 |
S |
p.
|
article
|
| 945 |
Small molecule-based angiogenic radiotracer for early detection and progression management of pulmonary arterial hypertension
|
Yang, Zhen
|
|
|
122-123 |
S |
p. S67
|
article
|
| 946 |
Solid phase radiosynthesis of an 18F labeled olaparib derivative for PET imaging of PARP expression
|
Zhou, Dong
|
|
|
122-123 |
S |
p. S222
|
article
|
| 947 |
Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis
|
Chasse, Melissa
|
|
|
122-123 |
S |
p. S23
|
article
|
| 948 |
Sortase mediated conjugation and 89Zr-radiolabelling of the HER2 neu targeting G3-DARPin for in vivo PET imaging in BT-474-xenografts
|
Fay, Rachael
|
|
|
122-123 |
S |
p. S89-S90
|
article
|
| 949 |
SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals
|
Mason, Julia
|
|
|
122-123 |
S |
p. S202-S203
|
article
|
| 950 |
Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90)
|
Landau, Felicitas
|
|
|
122-123 |
S |
p. S8
|
article
|
| 951 |
Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography
|
Wang, Lei
|
|
|
122-123 |
S |
p.
|
article
|
| 952 |
StarPEG Nanocarriers for Prostate Cancer Imaging and Drug Delivery
|
Meher, Niranjan
|
|
|
122-123 |
S |
p.
|
article
|
| 953 |
StarPEG Nanocarriers for PSMA Targeted Radioligand Imaging and Therapy
|
Bidkar, Anil
|
|
|
122-123 |
S |
p.
|
article
|
| 954 |
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4
|
Haider, Ahmed
|
|
|
122-123 |
S |
p. S25
|
article
|
| 955 |
Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate
|
Rahimi, Marwa
|
|
|
122-123 |
S |
p. S107
|
article
|
| 956 |
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry
|
Kronberger, Julia
|
|
|
122-123 |
S |
p.
|
article
|
| 957 |
Studies on the novel scandium-47 labelled PSMA inhibitor targeting ligand
|
Wojdowska, Wioletta
|
|
|
122-123 |
S |
p. S102
|
article
|
| 958 |
Studying the effect of structural modification of porphyrin derivatives on tumor uptake: Is lipophilicity the sole criterion?
|
Guleria, Mohini
|
|
|
122-123 |
S |
p. S45-S46
|
article
|
| 959 |
Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma
|
Nahas, Hanadi
|
|
|
122-123 |
S |
p. S41
|
article
|
| 960 |
Study of radiolabeled nanoplastics: synthesis and in vitro stability evaluation of Cu-64 and Lu-177 labeled polypropylene (PP)
|
Kim, Heejung
|
|
|
122-123 |
S |
p.
|
article
|
| 961 |
Subtype-selective vasopressin 1A receptor imaging by positron emission tomography
|
Haider, Ahmed
|
|
|
122-123 |
S |
p. S58
|
article
|
| 962 |
Supramolecular chemistry in the synthesis of radiopharmaceuticals
|
d’Orchymont, Faustine
|
|
|
122-123 |
S |
p. S34
|
article
|
| 963 |
Survey of the use of yttrium-90 in selective radiotherapy for primary liver cancer treatment
|
Tuan, Hoang
|
|
|
122-123 |
S |
p. S48
|
article
|
| 964 |
Syntheses and biological evaluation of two F-18 radiotracers for imaging MLKL in the brain
|
Huang, Tianyu
|
|
|
122-123 |
S |
p.
|
article
|
| 965 |
Synthesis and Astatine Labeling of a bis-iminobiotin derivative with enhanced plasma stability
|
Washiyama, Kohshin
|
|
|
122-123 |
S |
p. S121
|
article
|
| 966 |
Synthesis and bioevaluation of a novel SPECT agent targeting breast cancer estrogen receptor
|
Lin, Xiaoru
|
|
|
122-123 |
S |
p. S53
|
article
|
| 967 |
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity
|
Nag, Sangram
|
|
|
122-123 |
S |
p. S26
|
article
|
| 968 |
Synthesis and biological evaluation of 1-[2-(cyclopentadienyltr icarbonyltechnetium-99m)-N-vanillyferrocenecarboxamide for tumor imaging
|
Dallegi, Tesnim
|
|
|
122-123 |
S |
p. S51
|
article
|
| 969 |
Synthesis and characterization of new hydrophilic trithiol chelates and their radioarsenic complexes
|
Ma, Li
|
|
|
122-123 |
S |
p. S30
|
article
|
| 970 |
Synthesis and characterization of novel enrofloxacin derivatives and their rhenium and technetium-99m tricarbonyl complexes as potential therapeutic or diagnostic agents
|
Tzovas, Georgios
|
|
|
122-123 |
S |
p. S99
|
article
|
| 971 |
Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Radioligand Therapy Applications
|
Muzzioli, Riccardo
|
|
|
122-123 |
S |
p.
|
article
|
| 972 |
Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy
|
Veach, Darren
|
|
|
122-123 |
S |
p. S61-S62
|
article
|
| 973 |
Synthesis and evaluation of a fluorinated PET imaging probe targeting fibroblast activation protein (FAP)
|
Filippi, Nicolò
|
|
|
122-123 |
S |
p.
|
article
|
| 974 |
Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies
|
Kumar, Naveen
|
|
|
122-123 |
S |
p. S183-S184
|
article
|
| 975 |
Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake
|
Kuo, Hsiou-Ting
|
|
|
122-123 |
S |
p.
|
article
|
| 976 |
Synthesis and evaluation of an 18F labeled conformationally flexible benzamide analog ([18F]Fluoroethyl HY-2-92) for D3R PET Studies
|
Kim, Ho Young
|
|
|
122-123 |
S |
p. S96-S97
|
article
|
| 977 |
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography
|
Lu, Kelly
|
|
|
122-123 |
S |
p.
|
article
|
| 978 |
Synthesis and evaluation of a novel PET tracer for imaging monoamine oxidase-B
|
Fujinaga, Masayuki
|
|
|
122-123 |
S |
p.
|
article
|
| 979 |
Synthesis and evaluation of a radioligand for PET imaging of hepsin
|
Park, Ji-Hun
|
|
|
122-123 |
S |
p. S183
|
article
|
| 980 |
Synthesis and evaluation of 18F-labeled tracer candidates targeting the Abelson non-receptor tyrosine kinase in Parkinson’s disease
|
Stéen, E. Johanna
|
|
|
122-123 |
S |
p. S27
|
article
|
| 981 |
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for amyloid PET-imaging
|
Schlein, Eva
|
|
|
122-123 |
S |
p. S101-S102
|
article
|
| 982 |
Synthesis and evaluation of 68Ga-labeled [Leu13ψThz14] Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography
|
Wang, Lei
|
|
|
122-123 |
S |
p. S219
|
article
|
| 983 |
Synthesis and Evaluation of Modified NOTA Chelators Labeled with [99mTc]Tc/Re-Tricarbonyl for Potential Theranostic Agent Development
|
Kamboj, Ritin
|
|
|
122-123 |
S |
p.
|
article
|
| 984 |
Synthesis and evaluation of novel 18F-labeled indole-based derivatives as sigma-2 receptor radioligands for imaging the proliferative status of tumors
|
Zhang, Ying
|
|
|
122-123 |
S |
p. S197
|
article
|
| 985 |
Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R)
|
Rong, Jian
|
|
|
122-123 |
S |
p. S101
|
article
|
| 986 |
Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain
|
Mori, Wakana
|
|
|
122-123 |
S |
p. S99
|
article
|
| 987 |
Synthesis and evaluation of [186Re]Re(CO)3-p-NCS-benzyl-NODAGA-Ser2-RM2 for future development as a GRPR-antagonist for targeting prostate cancer
|
Hoerres, Rebecca
|
|
|
122-123 |
S |
p. S90-S91
|
article
|
| 988 |
Synthesis and in vitro and in vivo evaluation of a new 64Cu-semicarbazone complex: potential theranostic radiopharmaceutical for hypoxic tumor
|
Aljammaz, Ibrahim
|
|
|
122-123 |
S |
p. S52
|
article
|
| 989 |
Synthesis and in vitro stability evaluation of Cu-64 labeled branched polyethyleneimine (BPEI)
|
Choi, Se-hwan
|
|
|
122-123 |
S |
p.
|
article
|
| 990 |
Synthesis and in vitro stability evaluation of Cu-64 labeled linear polyethylenimine (LPEI) as a preliminary study
|
Jang, Jaebaek
|
|
|
122-123 |
S |
p.
|
article
|
| 991 |
Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging
|
Bailly, Thibaud
|
|
|
122-123 |
S |
p. S177-S178
|
article
|
| 992 |
Synthesis and optimization of radiotracers targeting P2Y12 receptors for positron emission tomography imaging of neuroinflammation
|
Pincemail, Eugénie
|
|
|
122-123 |
S |
p. S99-S100
|
article
|
| 993 |
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor
|
Högnäsbacka, Antonia
|
|
|
122-123 |
S |
p. S38-S39
|
article
|
| 994 |
Synthesis and preclinical evaluation of [18F]DASA-10 a second generation PKM2 specific radiotracer
|
Beinat, Corinne
|
|
|
122-123 |
S |
p.
|
article
|
| 995 |
Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors
|
Högnäsbacka, Antonia
|
|
|
122-123 |
S |
p. S51-S52
|
article
|
| 996 |
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN
|
Sadeghi, Saman
|
|
|
122-123 |
S |
p. S32
|
article
|
| 997 |
Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice
|
Tong, Jie
|
|
|
122-123 |
S |
p. S214
|
article
|
| 998 |
Synthesis and Preclinical Evaluation of Three Novel 68Ga-labeled PSMA-FAP Heterodimeric Tracers for Imaging of Prostate Cancer
|
Wang, Lei
|
|
|
122-123 |
S |
p.
|
article
|
| 999 |
Synthesis and preliminary evaluation of novel aminoimidazoline derivatives targeting the norepinephrine transporter
|
Lu, Jie
|
|
|
122-123 |
S |
p. S199
|
article
|
| 1000 |
Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals.
|
Carpanese, Debora
|
|
|
122-123 |
S |
p. S44-S45
|
article
|
Journal description